"dataset_name","analysis_key","analysis_number","subgroup_number","analysis_name","k","log_or","log_or_ci_lb","log_or_ci_ub","rd","rd_ci_lb","rd_ci_ub","or_sig","rd_sig","direction_match","mismatch_type","sparse_events","double_zero"
"CD000028_pub4_data","1::2",1,"2","All-cause mortality",11,0.0932493150659765,-0.112275250074066,0.298773880206019,0.0399949512151858,0.00109562825034308,0.0788942741800285,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD000143_pub2_data","2::overall",2,"overall","Endotracheal reintubation",23,-0.240630952618133,-0.554073512464801,0.0728116072285356,-0.0692555504467284,-0.137574243233744,-0.000936857659713242,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD000219_pub5_data","4::overall",4,"overall","Tympanic membrane perforation",7,-0.741655129157561,-1.4745339564142,-0.00877630190092582,-0.0167414916007323,-0.0361508894047324,0.0026679062032678,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD000219_pub5_data","5::overall",5,"overall","Contralateral otitis (in unilateral cases)",6,-0.435430088842618,-0.993564772979594,0.122704595294358,-0.0509061863009239,-0.099601333161406,-0.00221103944044176,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD000478_pub5_data","2::overall",2,"overall","Withdrawal due to adverse event",6,0.469376506878793,-0.291627289168017,1.2303803029256,0.0964145889662329,0.00926373329538287,0.183565444637083,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD000547_pub3_data","5::overall",5,"overall","Haemoglobin (preoperative)",25,-0.430563744150343,-0.808829066939871,-0.0522984213608142,-0.0385717406780236,-0.0793913542271233,0.00224787287107607,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD000547_pub3_data","6::overall",6,"overall","Postoperative morbidity (complications)",17,-0.749172512053013,-1.17649173979826,-0.321853284307771,-0.0149074373138737,-0.0340013574305625,0.00418648280281516,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD001155_pub3_data","4::overall",4,"overall","Wrist fractures",78,-0.258903149160523,-0.408375901813986,-0.109430396507059,-0.00179715119018787,-0.00568497056471581,0.00209066818434007,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD001155_pub3_data","6::overall",6,"overall","Withdrawals due to adverse events",40,-0.0175221304564189,-0.128062305300374,0.0930180443875357,0.00138003227089727,-0.00642630198600479,0.00918636652779932,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD001321_pub7_data","3::overall",3,"overall","Microbiological UTI: positive culture without known symptoms",8,-0.0353187757382847,-0.348810864256747,0.278173312780178,0.0143322263162177,-0.0252326987490909,0.0538971513815263,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD001321_pub7_data","5::overall",5,"overall","Gastrointestinal adverse events",10,0.334279996250128,-0.211570153510381,0.880130146010636,0.0080710934066093,0.00080373880766298,0.0153384480055556,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD001396_pub4_data","14::overall",14,"overall","Withdrawal due to adverse effects",26,0.234223902239026,-0.0349888309729762,0.503436635451027,0.0231949619015941,0.00339695112128241,0.0429929726819059,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD001431_pub6_data","1::overall",1,"overall","Informed values-choice congruence - all studies",437,0.0878065725772917,-0.0258150897684627,0.201428234923046,0.0269153465455197,0.00197309647122372,0.0518575966198158,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD001431_pub6_data","6::overall",6,"overall","Unclear values - old vs new studies",60,0.276397250757166,-0.101517737401048,0.65431223891538,0.0757616451729043,0.0152461086930892,0.136277181652719,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD001797_pub4_data","10::overall",10,"overall","Frequency of any side effects",3,1.49683600746359,0.770836371671796,2.22283564325538,0.210141204307698,-0.00885938138249381,0.42914178999789,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD001797_pub4_data","3::overall",3,"overall","Improvement ≥ 1 point on Rankin scale",5,0.880327102002256,-0.170883035962672,1.93153723996718,0.195636338194229,0.0418776986293676,0.349394977759089,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD001797_pub4_data","9::overall",9,"overall","Frequency of serious side effects",3,-0.238350754708517,-1.14755013561425,0.670848626197214,0.00342872467560969,-0.0494972326426615,0.0563546819938809,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD001909_pub4_data","5::overall",5,"overall","Somnolence",13,0.372785959428529,0.0452791676696823,0.700292751187375,0.0309194995917767,-0.00456941269287627,0.0664084118764296,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD001920_pub4_data","5::overall",5,"overall","Length of stay",141,-0.2182593643719,-0.471283541252354,0.0347648125085537,-0.0390783847551098,-0.0751974271201965,-0.00295934239002319,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD001920_pub4_data","6::overall",6,"overall","Adverse events",168,0.14414738056305,-0.131822929427141,0.420117690553241,0.0191211683220091,0.00384261253636482,0.0343997241076534,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD002042_pub6_data","11::overall",11,"overall","6-month mortality",2,0.272087163394509,-0.173710447772107,0.717884774561125,-0.0530739469391002,-0.323262076772857,0.217114182894657,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002042_pub6_data","13::overall",13,"overall","In-hospital mortality (as defined by triallists)",19,-0.142062167446524,-0.285521149964665,0.0013968150716176,-0.0110385014199588,-0.0176339989592867,-0.00444300388063088,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD002042_pub6_data","15::overall",15,"overall","Morbidity: cerebrovascular accident (CVA)",2,-0.0162237138279312,-2.28594369587419,2.25349626821832,5.80558234322239e-05,-0.0121806445452936,0.0122967561921581,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002042_pub6_data","19::overall",19,"overall","Morbidity: cerebrovascular accident (CVA) – stroke",29,0.102421574981109,-0.070450377614356,0.275293527576574,-0.0021695806743043,-0.00534500495809229,0.00100584360948368,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD002042_pub6_data","2::8",2,"8","Participants exposed to blood transfusion by clinical specialties",5,-1.23829451758935,-2.12786034472032,-0.348728690458372,-0.153005548634281,-0.333829947457895,0.0278188501893333,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD002042_pub6_data","31::overall",31,"overall","Morbidity: renal failure requiring dialysis/replacement therapy",9,0.0567319694286414,-0.232178221932549,0.345642160789832,-0.00309815050326758,-0.0117128373134344,0.00551653630689926,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD002042_pub6_data","32::overall",32,"overall","Morbidity: delirium",10,0.186229592896295,0.0328616128829879,0.339597572909603,0.0101494747568422,-0.0105697689220715,0.030868718435756,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD002042_pub6_data","6::overall",6,"overall","30-day mortality",44,0.0181395361852598,-0.120833573139454,0.157112645509974,-0.0012885343373158,-0.00768515604950555,0.00510808737487396,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD002042_pub6_data","8::1",8,"1","30-day mortality: subgroup by clinical specialties (random-effects model)",5,0.00193620178726427,-0.334972179120217,0.338844582694746,-0.00183043165969036,-0.008695028847848,0.00503416552846727,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD002042_pub6_data","9::1",9,"1","30-day mortality: subgroup by clinical specialties (fixed-effect model)",5,0.00193620178726427,-0.334972179120217,0.338844582694746,-0.00183043165969036,-0.008695028847848,0.00503416552846727,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD002052_pub4_data","3::overall",3,"overall","All‐cause mortality until hospital discharge",6,-0.0132990438117402,-0.779884443196963,0.753286355573483,0.00533895824849834,-0.083994389818222,0.0946723063152187,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002112_pub2_data","2::4",2,"4","Number of children achieving 14 consecutive dry nights by the end of treatment",8,0.548787418643163,-0.0737796537772848,1.17135449106361,0.0750577646446802,0.0251258658092371,0.124989663480123,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD002112_pub2_data","2::5",2,"5","Number of children achieving 14 consecutive dry nights by the end of treatment",4,-0.012158078447545,-0.547052538257894,0.522736381362804,0.00794967542453284,-0.0981512035712946,0.11405055442036,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD002112_pub2_data","2::6",2,"6","Number of children achieving 14 consecutive dry nights by the end of treatment",4,0.0111645307531015,-0.463810604597619,0.486139666103822,-0.00645595590712058,-0.0935399803088853,0.0806280684946441,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002112_pub2_data","3::overall",3,"overall","Number of children dry at follow-up (maintaining 14 consecutive dry nights after stopping treatment)",6,-0.595262401127139,-1.1572380914163,-0.0332867108379746,-0.121984821774187,-0.246303233729155,0.00233359018078039,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD002112_pub2_data","4::1",4,"1","Number of children dry at follow-up (maintaining 14 consecutive dry nights after stopping treatment)",12,0.415059973430352,-0.0131350315355879,0.843254978396293,0.0913183354976259,0.00436810990681041,0.178268561088441,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD002112_pub2_data","4::3",4,"3","Number of children relapsing after cessation of treatment",5,0.0818321895474927,-1.32398778397161,1.4876521630666,-0.0198683698688733,-0.291407693040723,0.251670953302976,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002122_pub3_data","1::3",1,"3","Pain (visual analogue scale)&nbsp;",4,-0.610111387508791,-1.57851446759405,0.358291692576464,-0.0544526947858061,-0.0906484303155796,-0.0182569592560326,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD002122_pub3_data","2::5",2,"5","Pain (4-point verbal rating scale)",6,0.029357410393524,-0.390325919186381,0.449040739973429,-0.000121551167099589,-0.0378986173098547,0.0376555149756555,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002122_pub3_data","2::8",2,"8","Adverse effects",4,-0.814118000525845,-1.64688937141372,0.0186533703620289,-0.0804970427426799,-0.12111281729484,-0.03988126819052,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD002122_pub3_data","3::1",3,"1","Pain (dichotomous)",6,-0.015417609003498,-0.551309975885319,0.520474757878323,0.0198075505275724,-0.0565733047532422,0.0961884058083871,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002122_pub3_data","3::2",3,"2","Pain (dichotomous)",6,0.0271236144041638,-0.598556386377016,0.652803615185343,-0.0267778726388821,-0.0925989406840341,0.0390431954062699,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002122_pub3_data","3::9",3,"9","Adverse effects",2,-0.0408224964287936,-1.01206442765006,0.93041943479247,0.0219085806942628,-0.109904499204171,0.153721660592697,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002122_pub3_data","6::1",6,"1","Quality of life",3,0.113075671418011,-0.619147918740918,0.845299261576939,-0.00195832337796727,-0.0673392400151204,0.0634225932591858,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD002122_pub3_data","6::10",6,"10","Adverse effects",3,-1.07379142921547,-1.86260931061117,-0.284973547819771,-0.106427021119375,-0.223869873793446,0.0110158315546954,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD002122_pub3_data","6::11",6,"11","Adverse effects",3,-1.87551324684182,-2.90621601798785,-0.844810475695792,-0.151268731614405,-0.303258832889974,0.000721369661165233,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD002122_pub3_data","6::5",6,"5","Adverse effects",2,-1.28504160280719,-2.35128470774317,-0.218798497871207,-0.125401728198048,-0.36649728512793,0.115693828731835,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD002122_pub3_data","7::16",7,"16","Adverse effects",3,0.208390908305619,-1.16643269951425,1.58321451612549,-0.00582632791533018,-0.0401357897559294,0.028483133925269,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002122_pub3_data","7::4",7,"4","Adverse effects",3,2.31853536430414,0.715250622442221,3.92182010616607,0.242336193302231,-0.0980183973777656,0.582690783982227,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD002122_pub3_data","7::7",7,"7","Adverse effects",3,-0.219304693653294,-3.68083498315127,3.24222559584468,0.0676407757235387,-0.191277730964719,0.326559282411797,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002122_pub3_data","7::8",7,"8","Adverse effects",3,-0.101157303167494,-0.905118722549963,0.702804116214975,0.00772346607950437,-0.0255634188319562,0.0410103509909649,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002203_pub5_data","13::overall",13,"overall","Acquisition of meticillin-resistant Staphylococcus aureus (MRSA)",5,0.0181766531826301,-0.593975483816248,0.630328790181508,-0.00526263172315449,-0.0324813218123256,0.0219560583660167,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD002203_pub5_data","14::overall",14,"overall","Acquisition of Haemophilus influenzae",4,-0.0320884736269821,-0.560999670158459,0.496822722904495,0.00196589473012878,-0.0381900467119024,0.04212183617216,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD002243_pub5_data","21::2",21,"2","Number of participants with adverse events",36,-0.047586720082244,-0.189825981102059,0.0946525409375708,0.000353130277469786,-0.0117156167747812,0.0124218773297208,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD002243_pub5_data","7::2",7,"2","28-day all-cause mortality by subgroups based on age",5,0.0594115393912813,-0.774696343619863,0.893519422402425,-0.0253460158285403,-0.0797212500277128,0.0290292183706322,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003129_pub2_data","7::overall",7,"overall","Withdrawals due to adverse events",5,0.772829936968409,-0.629541727338734,2.17520160127555,0.0273570614659632,0.00780523697342822,0.0469088859584981,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD003331_pub6_data","4::overall",4,"overall","Hospital admissions (all-cause) more than 12 months' follow-up",8,-0.487857614263124,-0.978326914856856,0.00261168633060882,-0.0989987525236258,-0.192617420984883,-0.0053800840623682,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD003333_pub4_data","2::overall",2,"overall","Non-fatal cardiovascular events (non-fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)",5,-0.232070922382987,-0.460090142540677,-0.00405170222529697,-0.0134553659407466,-0.0274193685787904,0.000508636697297218,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD003357_pub5_data","5::overall",5,"overall","Miscarriage rate per woman",3,0.140000336412752,-0.524640159555235,0.804640832380739,-0.0135118207440238,-0.0492652886511053,0.0222416471630578,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD003376_pub4_data","1::overall",1,"overall","Clinical vertebral fractures",98,-0.0979532814479582,-0.303986864444109,0.108080301548193,0.00518956749416327,-0.00265554806460928,0.0130346830529358,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003376_pub4_data","2::overall",2,"overall","Non-vertebral fractures",70,-0.031418176542453,-0.204630908291632,0.141794555206726,9.18372969363503e-05,-0.00965758445802354,0.00984125905189624,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003376_pub4_data","7::overall",7,"overall","Serious adverse events",8,-0.10961174207013,-0.715104108984887,0.495880624844627,0.00215247660905914,-0.0430431465899993,0.0473480998081176,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003414_pub4_data","1::1",1,"1","Live birth rate per woman",8,0.0529187781404367,-0.142072268059021,0.247909824339894,-0.000983367732137148,-0.0429212970664672,0.0409545616021929,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD003414_pub4_data","2::1",2,"1","Miscarriage rate per woman",14,-0.179236006968994,-0.540914702574039,0.18244268863605,-0.0168565838872494,-0.0317236348445612,-0.00198953292993758,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD003414_pub4_data","2::3",2,"3","Miscarriage rate per woman",5,-0.180486080810075,-0.856504943185137,0.495532781564986,-0.0234109961860165,-0.0419208994522768,-0.00490109291975618,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD003414_pub4_data","6::1",6,"1","Multiple pregnancy rate per woman",7,-0.0664681693954065,-0.511581878200526,0.378645539409713,0.00509539667654767,-0.0134509640040873,0.0236417573571826,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD003414_pub4_data","6::2",6,"2","Multiple pregnancy rate per woman",4,0.0640998192380396,-0.437438226927827,0.565637865403906,-0.00891276676038844,-0.0295251227495109,0.011699589228734,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD003414_pub4_data","6::3",6,"3","Multiple pregnancy rate per woman",3,0.00511885862637505,-0.615779938894454,0.626017656147204,-0.0127148276599632,-0.0589724012341408,0.0335427459142144,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD003429_pub5_data","10::3",10,"3","Adverse events",2,1.6094379124341,-0.574350043928056,3.79322586879626,0.0708572276970473,0.00255126762879093,0.139163187765304,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD003429_pub5_data","2::overall",2,"overall","Joint function protection (number of participants with no joint damage)",2,1.90872127253687,0.729146267412449,3.08829627766129,0.278577320015379,-0.0139592208706379,0.571113860901396,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD003429_pub5_data","3::overall",3,"overall","Sensitivity analysis (fixed-effect model): joint function protection (number of participants with no joint damage)",2,1.90872127253687,0.729146267412449,3.08829627766129,0.278577320015379,-0.0139592208706379,0.571113860901396,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD003594_pub7_data","1::2",1,"2","Complete remission",15,0.361887613119519,-0.0287426075657075,0.752517833804745,0.114831673147631,0.0343021829802839,0.195361163314978,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD003594_pub7_data","2::3",2,"3","Treatment response at 12 months",6,0.0888953452633987,-0.50884508564865,0.686635776175448,-0.00770553800396035,-0.143448216355189,0.128037140347269,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD003594_pub7_data","3::3",3,"3","Adverse events",2,-0.784693397917896,-2.75584492597659,1.1864581301408,-0.112523103484935,-0.206471782739967,-0.018574424229904,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD003594_pub7_data","4::4",4,"4","Adverse events",2,1.82901972025697,-0.341803675172463,3.99984311568641,0.101569939868854,0.0112779976319334,0.191861882105775,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD003594_pub7_data","4::5",4,"5","Adverse events",2,1.62140604006974,-0.573480305730688,3.81629238587017,0.090647214607629,0.00406646663399203,0.177227962581266,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD003594_pub7_data","6::2",6,"2","Adverse events (weeks 0 to 26)",2,-0.697399627111792,-1.69062353457476,0.295824280351171,-0.128646557152905,-0.247771609314298,-0.00952150499151165,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD003598_pub3_data","1::overall",1,"overall","All-cause death",66,-0.230942991272394,-0.412061783017353,-0.0498241995274354,-0.00617800539885085,-0.0139136935478458,0.00155768275014404,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD003598_pub3_data","10::overall",10,"overall","Any rejection",36,-0.0199798230453687,-0.277665865864769,0.237706219774032,0.00169084727570514,-0.0421423959940604,0.0455240905454707,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003598_pub3_data","11::overall",11,"overall","Acute rejection",36,0.0582727082595083,-0.217346028834687,0.333891445353704,-0.00559974880647313,-0.0296949734183648,0.0184954758054186,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003598_pub3_data","13::overall",13,"overall","Rejection rate",19,0.431912467927358,-0.120945770126119,0.984770705980836,0.0487054920760724,0.0123235440426086,0.0850874401095362,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD003598_pub3_data","14::overall",14,"overall","Proteinuria [g/24 hours]",16,-0.0193153028844573,-0.622060050392936,0.583429444624021,0.0230809262236071,-0.0190142970182121,0.0651761494654263,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003598_pub3_data","16::overall",16,"overall","Fatal myocardial infarction",12,0.0390026185686569,-0.672274784164642,0.750280021301956,0.0228884307244063,0.000352469860867032,0.0454243915879457,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD003598_pub3_data","18::overall",18,"overall","Any adverse event",8,-0.875290068506078,-1.48650267675993,-0.264077460252231,-0.12543240159083,-0.284545809609799,0.0336810064281397,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD003598_pub3_data","2::overall",2,"overall","Graft loss",60,-0.199730162087049,-0.360929664959141,-0.0385306592149563,-0.00432937951389666,-0.0118529884246521,0.00319422939685882,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD003598_pub3_data","28::overall",28,"overall","Withdrawal due to hypotension",10,0.732926331829942,-0.289848379967293,1.75570104362718,0.0233935777371534,0.00626870322099546,0.0405184522533114,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD003598_pub3_data","3::overall",3,"overall","Creatinine clearance [mL/min]",56,-0.197171237719586,-0.561985338706745,0.167642863267573,-0.0231460431393347,-0.0387439554876302,-0.00754813079103912,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD003598_pub3_data","31::overall",31,"overall","Peripheral oedema",2,-0.213131417608965,-0.782985275894513,0.356722440676584,0.00493507130323374,-0.0327783752551706,0.0426485178616381,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD003598_pub3_data","6::overall",6,"overall","Cardiovascular death",39,-0.079868171024321,-0.506172667025247,0.346436324976605,0.00290247600435454,-0.0249678702309499,0.030772822239659,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003598_pub3_data","7::overall",7,"overall","Systolic blood pressure [mm Hg]",20,0.0549254138062428,-0.332772577779456,0.442623405391941,-0.000746828625615281,-0.026055266845289,0.0245616095940584,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003774_pub5_data","11::overall",11,"overall","All-cause death and ganciclovir duration",41,-0.0882563806975551,-0.256388779928102,0.0798760185329922,0.00157241411237282,-0.0109008653228537,0.0140456935475994,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003774_pub5_data","9::overall",9,"overall","All-cause death according to CMV status",26,-0.0272244179674384,-0.351867657424765,0.297418821489888,0.00110699098526747,-0.0288158963164138,0.0310298782869487,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003962_pub3_data","1::overall",1,"overall","Kidney failure or doubling of serum creatinine",13,0.820182256605017,0.00304548622009027,1.63731902698994,0.132258050739616,-0.00389313517297193,0.268409236652205,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD003962_pub3_data","10::overall",10,"overall","> 50% increase in serum creatinine",11,-0.856302699582698,-1.70256942766573,-0.0100359714996626,-0.133421181249408,-0.400336722910942,0.133494360412126,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD003962_pub3_data","15::overall",15,"overall","Serious adverse events",6,0.306424588356311,-0.15734649408006,0.770195670792683,-0.00375074556237381,-0.0196208089531136,0.012119317828366,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003962_pub3_data","2::overall",2,"overall","Complete remission of proteinuria",20,-0.0842124768572457,-0.63321446044951,0.464789506735019,0.0085167521436394,-0.0796035526455005,0.0966370569327793,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD003962_pub3_data","3::overall",3,"overall","Partial remission of proteinuria",14,0.786631556862284,0.38529923983533,1.18796387388924,0.1070163540605,-0.0247796527581039,0.238812360879105,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD003962_pub3_data","4::overall",4,"overall","Proteinuria",36,-0.180481485612307,-0.585920482675328,0.224957511450713,0.145793552055092,-0.230908823829363,0.522495927939548,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004184_pub3_data","4::overall",4,"overall","Withdrawals from treatment due to adverse events",14,-0.294238213673217,-0.649642425150796,0.0611659978043628,-0.0128212394548341,-0.0247277558095662,-0.000914723100102148,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD004376_pub4_data","5::overall",5,"overall","Study withdrawals at final follow-up",123,-0.0185544313469562,-0.13573644350473,0.0986275808108178,0.00774549672347173,-0.00610585565159026,0.0215968490985337,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004406_pub6_data","1::overall",1,"overall","Resolution of symptoms post-treatment (ITT analysis)",17,-0.130284347592539,-0.272030322940448,0.0114616277553705,-0.0351578903720913,-0.0555489981690263,-0.0147667825751564,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD004508_pub5_data","5::overall",5,"overall","Abdominal distension",4,-0.0165633998531304,-0.429048472534218,0.395921672827957,0.0126463991399032,-0.0171195009962024,0.0424122992760088,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD004661_pub4_data","1::overall",1,"overall","Death (fetal, neonatal, or later (up to 2 years' corrected age))",50,-0.046339518921544,-0.133349874501788,0.0406708366587002,6.30668116141984e-05,-0.00212945178181328,0.00225558540504168,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004661_pub4_data","13::overall",13,"overall","Neonatal encephalopathy",18,0.696088830517675,0.0277969043571779,1.36438075667817,0.0715659847488908,-0.00454385101646271,0.147675820514244,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD004661_pub4_data","17::overall",17,"overall","Retinopathy of prematurity",4,-0.0095393677102157,-0.17907799925523,0.159999263834799,0.00309420951365953,-0.00347978231714147,0.00966820134446053,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD004661_pub4_data","5::overall",5,"overall","Death or major neurodevelopmental disability (up to 2 years' corrected age)",29,-0.0740864702713049,-0.167487318638181,0.0193143780955706,0.00121805687301906,-0.000492413620464634,0.00292852736650276,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004661_pub4_data","6::overall",6,"overall","Death (fetal, neonatal, or later (up to school age))",24,0.354462207559162,0.0465719072852781,0.662352507833045,0.0137041315423828,-0.000393031896626378,0.0278012949813919,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD004661_pub4_data","7::overall",7,"overall","Cerebral palsy (school age)",23,-0.00545331143910764,-0.0730159156549533,0.062109292776738,0.000400326472707336,-0.00829701385984319,0.00909766680525786,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD004661_pub4_data","9::overall",9,"overall","Major neurodevelopmental disability (school age)",22,0.738354633136911,0.244680481020839,1.23202878525298,0.0593302521674603,-0.00329659214083,0.121957096475751,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD004667_pub6_data","10::overall",10,"overall","Induction of labour",14,-0.102722121719142,-0.206700547318423,0.0012563038801386,-0.0169119233667792,-0.0333530469901066,-0.000470799743451874,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD004736_pub6_data","24::overall",24,"overall","Maternal severe anaemia at any time during second and third trimester (Hb less than 70 g/L): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",22,-0.170216111527597,-0.386395938385045,0.0459637153298519,0.000226097371665611,-0.00214595053443006,0.00259814527776128,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004736_pub6_data","28::overall",28,"overall","Low birthweight (less than 2500 g) (ALL)",26,-0.183171768442347,-0.310743467380259,-0.0556000695044339,-0.00374628619104179,-0.00849263600517785,0.00100006362309427,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD004736_pub6_data","31::overall",31,"overall","Low birthweight (less than 2500 g): SUBGROUP ANALYSIS by dose of iron",23,-0.230119748111369,-0.401833006035228,-0.0584064901875089,-0.0141630951603836,-0.0341394795622238,0.00581328924145664,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD004736_pub6_data","35::overall",35,"overall","Birthweight (g): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",30,-0.43016857970491,-0.933357510182941,0.073020350773121,0.0126490430677368,-0.0556472789185817,0.0809453650540554,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004736_pub6_data","36::overall",36,"overall","Birthweight (g): SUBGROUP ANALYSIS by dose of iron",34,-0.593359454389844,-1.08196195323069,-0.104756955548992,-0.0615334512584553,-0.149787573781884,0.0267206712649735,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD004736_pub6_data","40::overall",40,"overall","Preterm birth (less than 37 weeks of gestation): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",23,-0.0967272466077826,-0.193930573311961,0.000476080096395312,-0.00949378998145227,-0.0181732830187623,-0.000814296944142218,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD004736_pub6_data","44::overall",44,"overall","Neonatal death (within 28 days after delivery): SUBGROUP ANALYSIS by gestational age at the start of supplementation",8,-0.0437526497407454,-0.263410635510892,0.175905336029402,0.000240608375806571,-0.00408189338874027,0.00456311014035341,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004736_pub6_data","52::overall",52,"overall","Congenital anomalies: SUBGROUP ANALYSIS by malarial status of setting",7,-0.145286117391261,-0.503714580345171,0.213142345562648,0.000133755080313277,-0.00215514117191766,0.00242265133254421,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004736_pub6_data","62::overall",62,"overall","Severe anaemia postpartum (Hb less than 80 g/L) (ALL)",8,-0.0544764838389097,-0.428694120947859,0.31974115327004,-0.0318278480045122,-0.0578029362903352,-0.00585275971868929,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD004736_pub6_data","63::overall",63,"overall","Puerperal infection (ALL)",5,-0.378920121806349,-0.665024833688353,-0.0928154099243447,-0.010819490953763,-0.0279630522818255,0.00632407037429954,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD004736_pub6_data","65::overall",65,"overall","Postpartum haemorrhage (ALL)",3,-0.193571402895433,-0.750242631646708,0.363099825855843,0.00130337845499445,-0.00135426362566643,0.00396102053565534,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD004736_pub6_data","67::overall",67,"overall","Diarrhoea (ALL)",5,-0.674173541502027,-1.33984159516242,-0.00850548784163008,-0.0110161447011517,-0.0360656228338464,0.0140333334315431,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD004736_pub6_data","71::overall",71,"overall","Vomiting (ALL)",4,-0.0923277893751177,-0.568343431344619,0.383687852594383,0.0166389561406103,-0.0483452717611979,0.0816231840424184,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004953_pub5_data","1::2",1,"2","Death",2,-0.00363600388357654,-2.95079516916536,2.94352316139821,0.0634934678840171,-0.569790416130578,0.696777351898613,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD004953_pub5_data","13::2",13,"2","Patent ductus arteriosus (PDA)",4,-0.31193832717391,-1.31696208105697,0.693085426709153,0.00122630306136052,-0.0432607699035101,0.0457133760262312,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004953_pub5_data","2::overall",2,"overall","Death during hospitalisation",13,-0.063378770969754,-0.452932105680786,0.326174563741278,0.0123151431852662,-0.0251806352608016,0.049810921631334,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004953_pub5_data","3::2",3,"2","Death",12,-0.0807929145981088,-0.478495877235502,0.316910048039284,0.00930455824916111,-0.0309274632710097,0.0495365797693319,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD004953_pub5_data","6::overall",6,"overall","Pneumothorax during hospitalisation",13,-0.202375681961699,-0.609073523913697,0.204322159990299,0.00378972371786655,-0.0229426709806461,0.0305221184163792,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD004992_pub4_data","3::overall",3,"overall","Requirement for further endometrioma surgery",2,-1.61614048992132,-3.05782414181736,-0.174456838025279,-0.214690253913725,-0.545543169834251,0.1161626620068,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD005133_pub4_data","1::overall",1,"overall","All symptomatic CMV disease",21,-0.550256416915314,-1.1844586790761,0.0839458452454722,-0.082399938085971,-0.161379424015996,-0.00342045215594622,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD005133_pub4_data","2::overall",2,"overall","Death (any cause)",16,-0.0850674235903681,-0.543831414070006,0.37369656688927,0.00297128076956056,-0.0133515675232745,0.0192941290623956,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD005133_pub4_data","4::overall",4,"overall","CMV-associated symptoms",13,0.103865514236235,-0.34649825253974,0.55422928101221,-0.0320503501137118,-0.126149548551101,0.0620488483236777,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD005133_pub4_data","8::overall",8,"overall","Adverse events",56,-0.178646531411703,-0.343724842657834,-0.0135682201655713,-0.00780450238543387,-0.0228951107459063,0.00728610597503855,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD005187_pub6_data","4::overall",4,"overall","Deaths from lower respiratory tract infection ",6,-0.193051439968565,-0.641517327637778,0.255414447700648,0.00256148920930032,-0.00247880225992385,0.00760178067852449,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD005495_pub5_data","8::overall",8,"overall","Rate of cerebral palsy",36,-0.182422211047714,-0.41734177612702,0.0524973540315919,-0.0239807973078891,-0.0394174262426716,-0.00854416837310656,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD005566_pub4_data","2::overall",2,"overall","Cardiac complications, including 'no major complications'",108,0.172500361295016,0.115220497731308,0.229780224858723,0.00194394961143524,-0.000374855595181499,0.00426275481805198,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD005595_pub4_data","12::overall",12,"overall","Adverse events (after non-surgical fracture management)",38,-0.217882268505669,-0.622987955355863,0.187223418344525,-0.00932011576807357,-0.0168895485549436,-0.00175068298120357,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD005951_pub5_data","2::overall",2,"overall","Intracerebral haemorrhage expansion by 24 hours",14,-0.18016430137803,-0.339637968585686,-0.0206906341703736,-0.0464324272194671,-0.0944568293489188,0.00159197490998465,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD005951_pub5_data","6::overall",6,"overall","Death or dependence (Extended Glasgow Outcome Scale (GOS-E) 1–4) at day 90",4,-0.258853401184991,-0.501779033305092,-0.0159277690648904,-0.0327119025295902,-0.0799031377993745,0.0144793327401941,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD006023_pub4_data","10::overall",10,"overall","Hospitalisation",18,0.0249431377196293,-0.45417909653786,0.504065371977118,-0.0012860491676118,-0.0437973508643752,0.0412252525291516,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006023_pub4_data","11::overall",11,"overall","Fracture",18,-0.182258138529244,-0.546114957658765,0.181598680600277,0.000193714885864489,-0.00849205626286838,0.00887948603459736,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006023_pub4_data","12::overall",12,"overall","Pruritus",14,0.000647124871000849,-0.530374916150461,0.531669165892463,-0.00221588563914868,-0.0203575949018799,0.0159258236235825,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006023_pub4_data","19::overall",19,"overall","Serum calcium",31,0.268591967382393,-0.363355922657891,0.900539857422676,0.0219003692705481,0.00147593244492976,0.0423248060961664,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD006023_pub4_data","2::1",2,"1","Death (all causes): CKD GFR category",8,-1.04078578707877,-2.02194567355766,-0.0596259005998889,-0.0600418774394074,-0.124408754658315,0.00432499977950015,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006023_pub4_data","20::overall",20,"overall","Serum calcium-by-phosphate product",32,-0.0255643725247575,-0.585288794729191,0.534160049679676,0.00379676000894375,-0.0372087289734208,0.0448022489913083,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006023_pub4_data","5::overall",5,"overall","Constipation",54,0.266788792709498,-0.000848292037547105,0.534425877456542,0.0212961614760581,0.00574600770482712,0.0368463152472891,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD006023_pub4_data","7::overall",7,"overall","Coronary artery calcium score",28,0.478749595026122,0.0200805400225471,0.937418650029697,0.0189715124189477,-0.00327547205135776,0.0412184968892532,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006023_pub4_data","9::overall",9,"overall","Stroke",25,-0.587083189767351,-1.09046721542671,-0.0836991641079871,-0.0357945469907178,-0.0779559347236121,0.0063668407421766,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006027_pub3_data","2::overall",2,"overall","Need for rescue medication",33,-0.387063726097364,-0.790891201219947,0.0167637490252185,-0.0841748265335382,-0.165656527859762,-0.0026931252073147,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD006124_pub3_data","2::overall",2,"overall","Duration of procedure",16,0.0216934442945353,-0.61923555746931,0.662622446058381,-0.00647982677327379,-0.0230459372369804,0.0100862836904328,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006182_pub3_data","3::1",3,"1","Moderate to severe CP among surviving infants",10,0.324646105382712,-0.0160706105451358,0.66536282131056,0.0224495302098105,0.000259839463296861,0.0446392209563241,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD006182_pub3_data","5::1",5,"1","Mortality before 18 to 24 months",3,0.0776560249690618,-0.281656161188047,0.43696821112617,-0.0042292727017977,-0.051794507423982,0.0433359620203866,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD006182_pub3_data","7::1",7,"1","Sepsis",2,0.66199191682282,-0.640794869550294,1.96477870319593,0.0392967083475815,0.00660762506879956,0.0719857916263635,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD006185_pub6_data","7::4",7,"4","Lost to study during intervention phase, dropouts",4,0.558554943936061,-0.841019470554989,1.95812935842711,0.107538583648112,0.00246914033938896,0.212608026956835,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD006185_pub6_data","8::overall",8,"overall","Death from all causes until end of intervention phase",101,-0.0594288517194446,-0.449312869681266,0.330455166242377,0.0104413586985527,-0.0163753541118326,0.0372580715089381,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006257_pub2_data","1::overall",1,"overall","Death: any cause",123,-0.102536429609375,-0.301620773460066,0.0965479142413157,0.00254647441952697,-0.0324942886002363,0.0375872374392903,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006257_pub2_data","10::overall",10,"overall","GFR (at end of treatment) [mL/min/1.73 m²]",24,-0.375434774873434,-0.629298710553323,-0.121570839193545,-0.0586518589040451,-0.125761641922912,0.0084579241148216,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006257_pub2_data","16::overall",16,"overall","Impotence",5,0.0129511331073739,-1.19419457962757,1.22009684584232,-0.00245883687493299,-0.0746213145735622,0.0697036408236962,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006257_pub2_data","2::overall",2,"overall","Withdrawn",80,-0.0333495508961351,-0.335119525567279,0.268420423775009,0.0206988824965803,-0.0272786486429825,0.0686764136361432,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006257_pub2_data","3::overall",3,"overall","Cardiovascular death",102,-0.0293341543086401,-0.351903580469224,0.293235271851944,0.0133726591104857,-0.0589083263347963,0.0856536445557676,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006273_pub4_data","1::overall",1,"overall","Adverse events",4,1.44409540847358,-0.265810623902598,3.15400144084975,0.0724316587700779,0.0198378017671195,0.125025515773036,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD006404_pub5_data","1::overall",1,"overall","Total failure: day 28 (polymerase chain reaction-adjusted)",23,-0.565996737230503,-1.07653105580259,-0.0554624186584163,-0.00302966314313063,-0.00757229156201369,0.00151296527575244,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006404_pub5_data","10::24",10,"24","Other adverse events",2,-0.099412307807064,-0.685140178490315,0.486315562876187,0.00567481803622687,-0.0597563216992671,0.0711059577717209,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD006404_pub5_data","10::31",10,"31","Other adverse events",10,0.0853536979801662,-0.12614358939042,0.296850985350752,-0.00100910128709458,-0.00919210876766371,0.00717390619347455,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD006404_pub5_data","10::34",10,"34","Other adverse events",7,-0.017525451329874,-0.2218392333583,0.186788330698552,0.00202345596322868,-0.00887457814966597,0.0129214900761233,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD006404_pub5_data","10::37",10,"37","Other adverse events",2,0.0540596867473971,-2.16288728763749,2.27100666113228,-0.00173379828437145,-0.0380651651630996,0.0345975685943568,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD006404_pub5_data","11::overall",11,"overall","Subsequent treatment(s), alanine aminotransferase increase greater than five times the upper limit of normal",5,-0.0650650449828455,-1.08188876306454,0.951758673098853,0.00642550670515224,-0.00469099423680319,0.0175420076471077,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006404_pub5_data","2::overall",2,"overall","Total failure: day 42 (polymerase chain reaction-adjusted)",20,0.115084550986795,-0.235767329624593,0.465936431598184,-0.00190730317119628,-0.00665888977611205,0.00284428343371948,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006404_pub5_data","7::overall",7,"overall","Adverse events leading to withdrawal",20,0.485560068270137,-0.0370145744898418,1.00813471103012,0.00613554759856726,0.000354151114181483,0.011916944082953,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD006475_pub3_data","10::2",10,"2","Subgroup analysis: eczema by 2 years by probiotic type",16,-0.126712885073016,-0.276323050488693,0.0228972803426603,-0.0295234945742945,-0.055035309862747,-0.00401167928584199,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD006475_pub3_data","11::2",11,"2","Subgroup analysis: eczema by 2 years by period of supplementation",12,-0.121426684557418,-0.323550188471513,0.080696819356677,-0.0289453377497302,-0.0578842163874907,-6.45911196964916e-06,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD006475_pub3_data","4::2",4,"2","Subgroup analysis: eczema by 2 years of age by risk of allergy",5,0.00960308202462997,-0.229720033670684,0.248926197719944,-0.0121969771143441,-0.0808022816045158,0.0564083273758277,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD006475_pub3_data","5::1",5,"1","Subgroup analysis: eczema by 2 years of age by synbiotic type",2,-0.884504990324911,-2.53268524893936,0.763675268289534,-0.0907331200973501,-0.171654307970461,-0.00981193222423918,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD006475_pub3_data","5::overall",5,"overall","Cow's milk protein allergy by 2 years",5,0.0460037532774677,-0.606773761304945,0.698781267859881,-0.0108066882825203,-0.0467999308583871,0.0251865542933464,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD006475_pub3_data","8::2",8,"2","Subgroup analysis: eczema by 2 years by risk of allergy",9,-0.208418983992909,-0.446302750617334,0.0294647826315162,-0.0375796105608911,-0.0695200406897697,-0.00563918043201237,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD006536_pub5_data","1::overall",1,"overall","All-cause mortality",256,-0.245554815160856,-0.400776100614101,-0.0903335297076115,0.00507046159392783,0.00204939292172051,0.00809153026613516,TRUE,TRUE,FALSE,"direction_only",TRUE,TRUE
"CD006536_pub5_data","2::overall",2,"overall","Cardiovascular mortality",152,-0.227546018311185,-0.406717213253463,-0.0483748233689061,-0.00236376855210828,-0.00820561242199368,0.00347807531777712,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006536_pub5_data","6::overall",6,"overall","Incidence of arrhythmias",16,-0.0403289619519196,-0.448349731659396,0.367691807755557,0.00210497382360206,-0.0168391605242723,0.0210491081714764,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD006606_pub5_data","10::overall",10,"overall","Ovarian hyperstimulation syndrome – low risk of bias (risk ratio, random-effects)",2,-2.47099750788078,-4.54696304526511,-0.395031970496444,-0.0337777185921717,-0.0845473201252343,0.0169918829408909,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD006606_pub5_data","3::overall",3,"overall","Miscarriage – low risk of bias (odds ratio, random-effects)",2,0.504704692794523,0.015869621941178,0.993539763647868,0.0854478421060919,-0.00211511400419732,0.173010798216381,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD006606_pub5_data","4::overall",4,"overall","Miscarriage – low risk of bias (risk ratio, random-effects)",2,0.504704692794523,0.015869621941178,0.993539763647868,0.0854478421060919,-0.00211511400419732,0.173010798216381,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD006606_pub5_data","9::overall",9,"overall","Ovarian hyperstimulation syndrome – low risk of bias (odds ratio, random-effects)",2,-2.47099750788078,-4.54696304526511,-0.395031970496444,-0.0337777185921717,-0.0845473201252343,0.0169918829408909,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD006689_pub3_data","10::overall",10,"overall","Mean haemoglobin at delivery (in g/dL)",14,0.0845159962053189,-0.162018077761042,0.33105007017168,-0.00274456219255169,-0.0106193234749306,0.0051301990898272,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006689_pub3_data","14::overall",14,"overall","Cord blood parasitaemia (blood smear)",17,-0.219916184062995,-0.664689882539445,0.224857514413454,-0.00488066238984394,-0.00967451529309968,-8.68094865881927e-05,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD006689_pub3_data","17::overall",17,"overall","Severe adverse events during pregnancy",14,-0.220256547864931,-0.434577630440819,-0.00593546528904385,-0.00504995796178012,-0.0160413850985532,0.00594146917499298,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006689_pub3_data","2::overall",2,"overall","Maternal peripheral parasitaemia at delivery (microscopy)",16,-0.100163048844305,-0.334262201247094,0.133936103558485,0.00169558318662264,-0.00266782895197951,0.0060589953252248,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD006689_pub3_data","21::overall",21,"overall","Neonatal mortality",8,0.445282532134804,0.072679473052233,0.817885591217374,0.00901800904292972,-0.00222372103684197,0.0202597391227014,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD006742_pub3_data","1::overall",1,"overall","All-Cause Mortality",5,-0.154522745513766,-0.479062428235904,0.170016937208371,0.000180519361529113,-0.00629119652549557,0.0066522352485538,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD006742_pub3_data","3::overall",3,"overall","Stroke",4,-0.747200201730752,-1.45988115539871,-0.0345192480627884,-0.0215752673936395,-0.066320434188383,0.0231698994011041,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006913_pub3_data","12::1",12,"1","Quality of life (short-term), by therapy intensity - psychotherapy vs care-as-usual",53,-0.340665329068274,-0.637465635211707,-0.0438650229248396,-0.0546102308215401,-0.109269458673543,4.89970304623499e-05,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD006913_pub3_data","7::2",7,"2","Quality of life (long-term), by disease activity - psychotherapy vs care-as-usual",12,-0.657102826383977,-1.32745500617408,0.0132493534061243,-0.156825786106691,-0.308613028881275,-0.00503854333210632,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD006913_pub3_data","8::2",8,"2","Quality of life (short-term), by comorbidity - psychotherapy vs care-as-usual",33,-0.298473959996694,-0.649777878919093,0.0528299589257039,-0.16516730104143,-0.318687855776881,-0.011646746305978,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD007026_pub7_data","1::overall",1,"overall","All-cause death",14,-0.0635322314121184,-0.360606222299671,0.233541759475434,0.0135677110904408,-0.00171933115276032,0.0288547533336419,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD007026_pub7_data","2::overall",2,"overall","Non-death attrition",14,-0.312085750766122,-0.511764346594512,-0.112407154937733,-0.0174150488019581,-0.056585154040554,0.0217550564366378,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD007026_pub7_data","4::overall",4,"overall","Total number of people with fatal SAEs",10,-0.086144364241304,-0.394195188018704,0.221906459536096,0.00733489049058759,-0.0103726910678012,0.0250424720489763,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD007026_pub7_data","5::overall",5,"overall","Total number of people with non-fatal SAEs",3,0.940440812987686,0.0935367798454765,1.7873448461299,0.00844924865575964,-0.0209611933344418,0.0378596906459611,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD007079_pub4_data","4::overall",4,"overall","Preterm birth < 37 weeks' gestation by type of calcium",17,-0.176063558256093,-0.349617311279333,-0.00250980523285194,-0.00022677532838552,-0.00195253345925248,0.00149898280248144,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD007130_pub5_data","1::overall",1,"overall","Total mortality",14,0.183065910050036,-0.415742352708338,0.781874172808409,-0.00175274054309054,-0.0157612663704424,0.0122557852842613,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD007310_pub3_data","15::overall",15,"overall","Provider assessment of difficulty of procedure",3,1.21027853220094,-0.136792709878694,2.55734977428058,0.141160352459429,0.0517419130874872,0.23057879183137,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD007310_pub3_data","16::overall",16,"overall","Provider assessment of the procedure as very difficult",3,-0.487596754889264,-0.927411528450317,-0.0477819813282109,-0.0575544421390149,-0.119109906565795,0.00400102228776571,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD007374_pub3_data","17::overall",17,"overall","Glycaemic events",2,-1.06001083680698,-3.0599015978727,0.939879924258735,-0.0707961994475536,-0.119726611708156,-0.0218657871869511,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD007388_pub3_data","2::overall",2,"overall","Maternal death",11,-0.129655697108189,-0.416207684615033,0.156896290398655,0.000425557881605592,-0.0262781732868258,0.0271292890500369,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD007572_pub4_data","2::1",2,"1","Failure to induce clinical remission (subgroup analyses anti-TNF pre-treated vs anti-TNF naive participants)",3,-0.791190127636766,-1.58975805690958,0.00737780163604718,-0.164521027953021,-0.323385638852449,-0.00565641705359221,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD007572_pub4_data","3::2",3,"2","Failure to induce clinical remission (8 weeks, sensitivity analysis)",3,-0.972118795710193,-1.40701568934965,-0.537221902070736,-0.0946709401373849,-0.238587873010166,0.0492459927353966,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD007572_pub4_data","4::1",4,"1","Failure to induce clinical response (≥ 100 points)",2,-0.678419975011292,-1.22548039401332,-0.131359556009264,-0.0666178245978004,-0.13445213104156,0.00121648184595941,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD007572_pub4_data","7::overall",7,"overall","Failure to induce endoscopic response",4,-0.556554217941361,-1.18635049939652,0.0732420635137958,-0.116138349050135,-0.177163883473101,-0.0551128146271681,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD007639_pub3_data","2::overall",2,"overall","Increased cough (Sidestream versus Pari LC plus)",22,0.367998881607187,-0.351490655106946,1.08748841832132,0.0158779736050253,0.000247250502035782,0.0315086967080148,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD007639_pub3_data","5::overall",5,"overall","FEV1 (% predicted)",10,-0.764158045813627,-1.11554982871089,-0.412766262916362,-0.141530791985058,-0.442164894022115,0.159103310051999,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD007784_pub3_data","3::overall",3,"overall","Rhabdomyolysis",3,-0.409956491981022,-0.71440350957881,-0.105509474383235,-0.00955737054807002,-0.0326904043559082,0.0135756632597682,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD007784_pub3_data","56::overall",56,"overall","Sensitivity analysis (funding): death",5,-0.333155073731076,-0.842391258309594,0.176081110847442,-0.0113321243083082,-0.0198857015507223,-0.00277854706589422,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD007784_pub3_data","7::overall",7,"overall","Revascularisation procedure",4,-0.549279520548809,-0.869575994898571,-0.228983046199048,-0.0219248322924297,-0.0539743864609231,0.0101247218760636,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD007809_pub3_data","5::overall",5,"overall","Number of participants withdrawing due to an adverse event at 12 weeks",9,-0.0174567850363667,-0.601596877800124,0.56668330772739,0.000485757686014773,-0.0827822502562498,0.0837537656282793,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD007872_pub4_data","7::overall",7,"overall","Receipt of blood transfusion",3,0.00329447663188721,-0.0697808181156959,0.0763697713794704,-0.000311729292843516,-0.00576677335304376,0.00514331476735673,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD007895_pub3_data","4::overall",4,"overall","Withdrawals due to adverse effects",4,0.196826959380934,-1.00236160155773,1.3960155203196,-0.00230091056532201,-0.0139635760205803,0.00936175488993631,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD008176_pub3_data","1::overall",1,"overall","Cardiovascular death",26,-0.0332363247226825,-0.193586397855499,0.127113748410134,0.00501834957293128,-0.00148190160879529,0.0115186007546579,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD008176_pub3_data","19::overall",19,"overall","Vascular access thrombosis",19,-0.0745641392244401,-0.38406929094238,0.234941012493499,0.0181312761329454,-0.00122332886379583,0.0374858811296867,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD008176_pub3_data","20::overall",20,"overall","Graft loss",23,-0.0674262005185609,-0.363407812368353,0.228555411331231,0.0117520897877207,-0.00484923748970844,0.0283534170651498,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD008176_pub3_data","21::overall",21,"overall","Graft failure",16,-0.109563733169397,-0.406270457297592,0.187142990958799,0.0074112026948939,-0.0158220918549762,0.030644497244764,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD008176_pub3_data","23::overall",23,"overall","Malignancy",12,-0.119905323752257,-0.915799396483503,0.675988748978988,0.0121782398272486,-0.000863840231037812,0.0252203198855351,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD008176_pub3_data","4::overall",4,"overall","Coronary heart disease",42,-0.284497042365989,-0.485907138790454,-0.0830869459415242,-0.000574068648884369,-0.00588092838679182,0.00473279108902308,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD008176_pub3_data","6::overall",6,"overall","Cerebrovascular disease",24,-0.0538890516063148,-0.251987913018853,0.144209809806223,0.00176188832790052,-0.00822969899229911,0.0117534756481002,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD008176_pub3_data","7::overall",7,"overall","Peripheral vascular disease",14,-0.310612305026753,-0.680486594145829,0.0592619840923237,-0.0172933706611961,-0.0339882533046458,-0.000598488017746431,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD008237_pub4_data","3::1",3,"1","Independent procedure completion: level of participant endoscopy experience",3,0.862458825519725,0.0399804493995793,1.68493720163987,0.178395543044035,-0.000131246011832981,0.356922332099903,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD008309_pub3_data","12::overall",12,"overall","Pulmonary air leak, any (during first hospitalisation)",7,0.459389089844862,-0.247132262997881,1.1659104426876,0.0605206480591759,0.0062384213728997,0.114802874745452,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD008309_pub3_data","15::overall",15,"overall","BPD (clinical definition) among survivors to 36 weeks' PMA",5,0.247459313573719,-0.806635654694913,1.30155428184235,-0.00119395812295877,-0.0609469025973489,0.0585589863514314,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD008309_pub3_data","3::overall",3,"overall","Bradycardia (heart rate < 100 beats per minute) during the intervention",20,-0.0478374859738786,-0.440125289519186,0.344450317571429,0.0209645704971793,-0.00798515414753002,0.0499142951418886,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD008469_pub3_data","4::overall",4,"overall","Day symptoms (change in mean symptom-free days in 2 weeks)",6,-1.14672505310754,-2.06842420060758,-0.225025905607505,-0.166819589918621,-0.372222447441015,0.0385832676037727,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD008469_pub3_data","6::overall",6,"overall","Exacerbations leading to hospitalisations: subgrouped by time frame of follow-up",11,0.282976800756342,0.0111167154346984,0.554836886077986,0.028224411387888,-0.0160800169890586,0.0725288397648347,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD008493_pub5_data","1::overall",1,"overall","Short-term mortality",20,0.243592105655402,-0.0840426236919071,0.571226835002711,0.00276085597039042,0.000514962058386997,0.00500674988239384,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD008493_pub5_data","4::overall",4,"overall","Atrial fibrillation",17,-0.0273744335751485,-0.291537930201692,0.236789063051396,0.00396071067818513,-0.000590186767374353,0.0085116081237446,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD008564_pub3_data","1::overall",1,"overall","Total mortality",56,-0.105786796978427,-0.196432230277643,-0.0151413636792118,-0.00545398389372223,-0.0112587100102629,0.000350742222818415,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD008564_pub3_data","4::overall",4,"overall","Cardiovascular mortality",56,-0.103491548743915,-0.215056321709806,0.00807322422197483,-0.00309463624300183,-0.00604688059899377,-0.000142391887009882,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD008564_pub3_data","5::overall",5,"overall","Progression to end-stage renal disease ",38,-0.0709223555153477,-0.159095402126999,0.0172506910963032,-0.0035532583286281,-0.00623464985531079,-0.0008718668019454,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD008564_pub3_data","7::overall",7,"overall","Doubling of serum creatinine level or 50% reduction in GFR at the end of study",5,0.0882666963133817,-0.382929837575328,0.559463230202091,-0.000730799403602747,-0.00635330688823517,0.00489170808102967,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD008709_pub4_data","1::overall",1,"overall","Objective cure or improvement of urinary incontinence: between 12 and 24 months",27,-0.195530394690797,-0.374318453311962,-0.0167423360696326,-0.0160931330717292,-0.0365453952067787,0.00435912906332025,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD008709_pub4_data","11::overall",11,"overall","Other injuries: less than 30 days after surgery",8,-0.970338986486536,-1.8296535515181,-0.111024421454974,-0.00622542925665033,-0.0166943041810398,0.00424344566773913,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD008709_pub4_data","12::overall",12,"overall","Infections (e.g. UTI, mesh infection)",16,-0.245406787685041,-0.619713266680044,0.128899691309962,0.00404298218822112,-0.00502906374316556,0.0131150281196078,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD008709_pub4_data","4::overall",4,"overall","Bladder or urethral injuries: less than 30 days after surgery",10,-0.339545397800675,-0.637479543288352,-0.041611252312997,-0.0186369424413836,-0.0649790625233309,0.0277051776405636,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD008873_pub5_data","4::overall",4,"overall","Preterm birth (less than 37 weeks' gestation) (ALL)",5,0.0879061649033196,-0.222544881616169,0.398357211422808,-0.0070025358648487,-0.0426919424243994,0.028686870694702,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD009022_pub4_data","9::overall",9,"overall","Wound infection (rate)",5,0.0965059476202391,-0.771102763945421,0.964114659185899,-0.00907767474733215,-0.0397511496074066,0.0215958001127423,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD009102_pub2_data","3::overall",3,"overall","Chest compressions in DR",3,-1.15874650353003,-2.29532780454644,-0.022165202513613,-0.0372263102146659,-0.083019716793849,0.00856709636451734,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD009235_pub4_data","13::overall",13,"overall","Tracheostomy",17,-0.368769457336328,-0.624587586675582,-0.112951327997074,-0.0260374478617381,-0.0548073520485182,0.00273245632504205,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD009235_pub4_data","16::1",16,"1","Reintubation by study population",3,-0.450791686585743,-1.38254399333389,0.480960620162401,-0.0465646710784388,-0.0861664977113325,-0.00696284444554519,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD009235_pub4_data","16::3",16,"3","Reintubation by study population",11,-0.0815664708056668,-0.526053843356774,0.362920901745441,0.00784643761171311,-0.0211329347585962,0.0368258099820224,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD009235_pub4_data","19::5",19,"5","Reintubation by automated system",3,-0.636903750253323,-1.16259337091444,-0.111214129592207,-0.053775516241401,-0.131335454845542,0.02378442236274,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD009298_pub3_data","15::2",15,"2","Caesarean section (Subgroup analysis: nulliparous versus multiparous)",5,-1.15718526808336,-2.68663179641463,0.372261260247919,-0.0451679560791295,-0.0869635443380936,-0.00337236782016539,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD009298_pub3_data","2::2",2,"2","Operative delivery (Subgroup analysis: occiput posterior versus occiput transverse)",2,0.0128415025460249,-0.591349688361195,0.617032693453244,-0.00153767152139199,-0.147962947336142,0.144887604293358,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD009298_pub3_data","26::1",26,"1","Postpartum haemorrhage ≥ 500 mL (Subgroup analysis: occiput posterior versus occiput transverse position)",5,-0.00230850329454031,-0.405698277171789,0.401081270582708,0.00842220213852461,-0.0339576489131695,0.0508020531902187,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD009508_pub2_data","4::overall",4,"overall","Satisfaction",6,0.532751809728883,0.035863712121223,1.02963990733654,0.110093772801052,-0.0320333653129495,0.252220910915053,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD009531_pub3_data","14::overall",14,"overall","Death",5,0.228150255134118,-0.561565474648799,1.01786598491704,-0.00313151059750426,-0.0135914848717499,0.00732846367674141,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD009531_pub3_data","2::overall",2,"overall","Mental state: clinically important change (binary) - 12 months ",31,-0.26797923241828,-0.529598927407602,-0.00635953742895717,-0.0358121693287788,-0.121613946029057,0.0499896073714992,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD009531_pub3_data","3::overall",3,"overall","Psychiatric hospital admissions - 12 months",8,-0.40710472100089,-0.730244488314869,-0.0839649536869102,-0.0473751110394831,-0.159048293811185,0.0642980717322187,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD009531_pub3_data","4::overall",4,"overall","Other hospital admissions",8,-0.432932984183495,-0.74831878145228,-0.11754718691471,-0.0540694357942659,-0.170445142796139,0.0623062712076069,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD009535_pub3_data","5::overall",5,"overall","Kidney transplantation during study period",6,0.397075952617395,-0.00914913822627278,0.803301043461064,0.0529148879064974,0.0141559780535061,0.0916737977594886,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD009679_pub3_data","3::overall",3,"overall","WOMAC Pain score",9,0.149456500225736,-0.782624954519947,1.08153795497142,-0.0201699562257942,-0.0559337357735404,0.0155938233219521,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD009749_pub3_data","10::overall",10,"overall","Sensitivity analyses ",25,0.0593752968313192,-0.142777267771774,0.261527861434413,-0.00142050005567651,-0.017899063779527,0.015058063668174,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD009749_pub3_data","4::overall",4,"overall","Miscarriage rate - T",12,0.372000978127375,-0.393847129180738,1.13784908543549,0.0278847460396823,0.00110373026215686,0.0546657618172078,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD009749_pub3_data","7::overall",7,"overall","Multiple pregnancy",11,0.473065617305593,-0.536821464723028,1.48295269933422,0.0251961106248765,0.000758942528019092,0.049633278721734,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD009749_pub3_data","9::overall",9,"overall","Pregnancy complications",4,1.36535002071751,-0.222254359917541,2.95295440135257,0.0341416506696905,0.0033408184796069,0.0649424828597742,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD009752_pub3_data","6::overall",6,"overall","Severe adverse events: thromboembolism",2,0.345868650387439,-0.834701525496782,1.52643882627166,-0.0031131383245739,-0.0400551506946671,0.0338288740455194,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD009945_pub3_data","2::overall",2,"overall","Treatment withdrawal",3,-0.0390559697778393,-1.46439703887278,1.38628509931711,0.0266269701173344,-0.00917569991499588,0.0624296401496646,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD010001_pub4_data","5::overall",5,"overall","Endometrial thickness",33,0.452078687711738,0.039879660205733,0.864277715217742,0.162490138797606,-0.0598926681715143,0.384872945766726,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD010145_pub2_data","1::overall",1,"overall","Adverse events (related to the study treatment)",3,0.459724390546371,-0.380775586546137,1.30022436763888,0.0987720647176997,0.00142413374362066,0.196119995691779,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD010145_pub2_data","11::1",11,"1","Three-year survival rate",3,1.77718102470643,0.569357964639295,2.98500408477357,0.28945680196051,-0.0677916492195541,0.646705253140574,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD010145_pub2_data","2::2",2,"2","Adverse event (fatigue)",2,-1.24306295667644,-2.27194859564514,-0.214177317707742,-0.111077107068059,-0.258970581073014,0.0368163669368966,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD010216_pub9_data","2::overall",2,"overall","Adverse events",32,0.189886224228429,-0.0176860567046192,0.397458505161478,0.0370966809085067,0.000375659410461623,0.0738177024065519,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD010290_pub4_data","12::overall",12,"overall","Sensitivity analysis: live birth rate per woman - low risk studies",3,0.124490838389731,-0.373217070203522,0.622198746982985,-0.000278158063669968,-0.0221214406363575,0.0215651245090175,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD010290_pub4_data","3::overall",3,"overall","Multiple pregnancy per woman by urinary gonadotropins",13,0.432994455628157,0.164758694381644,0.70123021687467,0.0102229722651363,-0.0214719279613488,0.0419178724916215,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD010441_pub3_data","4::overall",4,"overall","Incidence of third and fourth degree perineal trauma",6,-0.48044360826519,-1.44592920275651,0.485041986226131,-0.0456308269835064,-0.0876826378894239,-0.00357901607758888,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD010533_pub3_data","1::overall",1,"overall","Overall survival (OS)",22,-0.0222034949929907,-0.811256838375917,0.766849848389935,0.023314612466805,-0.247932409552122,0.294561634485732,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD010583_pub6_data","1::2",1,"2","Mortality (30 days)",3,-1.65735807521803,-3.50275781462415,0.188041664188092,-0.0310596513337534,-0.062100674775297,-1.86278922098305e-05,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD010583_pub6_data","2::2",2,"2","Intra-abdominal infection",2,-1.03901818109248,-1.77231823401289,-0.305718128172066,-0.0906971261981384,-0.206340471826021,0.0249462194297445,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD010861_pub3_data","10::overall",10,"overall","Flushing/Fishbane reaction",5,1.51570181602945,0.0936845119966714,2.93771912006223,0.0428582091733908,-0.0106552573107165,0.0963716756574981,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD010861_pub3_data","15::overall",15,"overall","Number of RBC transfused women",5,-0.28729155008957,-1.52630817322432,0.951725073045184,0.00222133059189876,-0.00560224357296729,0.0100449047567648,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD010861_pub3_data","5::overall",5,"overall","Psychological wellbeing",6,0.509021021827719,-0.147393688210087,1.16543573186552,-0.060004896292956,-0.252253670002629,0.132243877416717,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD010861_pub3_data","7::overall",7,"overall","Compliance to treatment",14,1.27357149948146,0.316901399297633,2.23024159966529,0.108703832781923,-0.00889237020930962,0.226300035773155,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD010966_pub4_data","1::overall",1,"overall","FEV1 % predicted (absolute change from baseline)",65,-0.207750252671045,-0.673556970156986,0.258056464814896,-0.0819815913269149,-0.1207064162904,-0.0432567663634297,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD010966_pub4_data","16::overall",16,"overall","Most common adverse events (occurring in at least 10% of participants in either group)",69,-0.207976073333071,-0.321521973251102,-0.0944301734150395,-0.000957071316611077,-0.0202428771011532,0.018328734467931,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD010966_pub4_data","2::overall",2,"overall","Adverse effects: 100 mg and 200 mg lumacaftor groups (combined data) versus placebo at up to 1 month",141,-0.102162499947729,-0.310532954451865,0.106207954556406,0.0287492150521981,0.0150973340891456,0.0424010960152505,FALSE,TRUE,FALSE,"direction_and_significance",TRUE,TRUE
"CD010966_pub4_data","3::overall",3,"overall","Adverse effects: 200 mg lumacaftor group versus placebo at up to 1 month",121,-0.156314503905124,-0.410530648038037,0.0979016402277896,0.00286798264544102,-0.0306023682313756,0.0363383335222577,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD010966_pub4_data","4::overall",4,"overall","Adverse effects requiring study drug discontinuation at up to 1 month",451,-0.0778155637605283,-0.195390192005482,0.0397590644844249,0.0168192333958693,0.00451581171014535,0.0291226550815932,FALSE,TRUE,FALSE,"direction_and_significance",TRUE,TRUE
"CD010966_pub4_data","5::overall",5,"overall","Sweat chloride concentration (change from baseline at up to 1 month) [mmol/L]",112,-0.0988757407469023,-0.334396255569982,0.136644774076178,0.0237719933344068,0.00663519284044899,0.0409087938283647,FALSE,TRUE,FALSE,"direction_and_significance",TRUE,TRUE
"CD011197_pub3_data","1::overall",1,"overall","Mortality",9,0.0642697992495557,-0.369310527324017,0.497850125823128,-0.00829822415495263,-0.0245626993423992,0.00796625103249392,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011204_pub3_data","9::overall",9,"overall","Proportion of participants experiencing agitation",7,0.206795376013072,-0.0498724454850453,0.463463197511188,0.0196147674563833,5.18993788500843e-05,0.0391776355339165,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD011305_pub3_data","10::overall",10,"overall","Severe bleeding - WHO/CTCAE grade ≥ 3 or equivalent (0 to 3 months)",5,0.00272529222196641,-1.01646249473177,1.02191307917571,-0.00211768333568689,-0.0270250551117067,0.0227896884403329,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD011381_pub3_data","11::overall",11,"overall","Mortality",32,-0.131037295500384,-0.613760809023011,0.351686218022242,0.000164999111769419,-0.000759477338704154,0.00108947556224299,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD011468_pub2_data","1::overall",1,"overall","Secondary patency",5,-1.15170600602171,-1.87955177338036,-0.423860238663057,-0.166838204117639,-0.381339394543753,0.0476629863084745,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011535_pub7_data","1::12",1,"12","Biologic 1 versus biologic 2",2,0.318265200615272,0.017371605010959,0.619158796219585,0.023757495680453,-0.0339719137961629,0.081486905157069,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011535_pub7_data","1::5",1,"5","Biologic 1 versus biologic 2",2,1.05632741436661,0.0613926807160821,2.05126214801713,0.179844043011878,-0.039664840830956,0.399352926854711,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011535_pub7_data","1::8",1,"8","Biologic 1 versus biologic 2",2,0.967100075280519,0.165162212109754,1.76903793845128,0.177854377075344,-0.0474460570023162,0.403154811153005,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011535_pub7_data","12::6",12,"6","Anti-IL17 versus other biologics",4,0.469035989378385,0.0613405242051552,0.876731454551614,0.0910862640635742,-0.00339077657954853,0.185563304706697,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011535_pub7_data","2::overall",2,"overall","Ciclosporin versus methotrexate",15,0.0793350126264886,-0.450267834820286,0.608937860073263,-0.0060921389303748,-0.148629026591266,0.136444748730516,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011535_pub7_data","6::4",6,"4","Anti-IL17 versus placebo",5,1.72280140027586,-0.337294098514521,3.78289689906625,0.275307989831499,0.0568928346731288,0.49372314498987,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD011535_pub7_data","8::20",8,"20","Biologics versus non-targeted treatements",5,1.9408549201232,-0.489982037650103,4.3716918778965,0.354610578139345,0.00201651783008633,0.707204638448603,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD011535_pub7_data","8::23",8,"23","Biologics versus non-targeted treatements",5,1.42104786138118,-0.0922394540663893,2.93433517682874,0.311594462310238,0.0207730826118454,0.60241584200863,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD011535_pub7_data","9::2",9,"2","Etanercept versus other anti-TNF alpha",5,-0.258838376628789,-0.449029954614739,-0.0686467986428376,-0.0354876776136139,-0.0725281254915158,0.00155277026428795,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011535_pub7_data","9::3",9,"3","Etanercept versus other anti-TNF alpha",5,-1.59171729937543,-2.35543338214269,-0.828001216608164,-0.20443127479707,-0.413576481704366,0.00471393211022608,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD011575_pub3_data","15::overall",15,"overall","Stroke (excluding Wei)",3,0.22927397687031,-0.080389960617132,0.538937914357751,0.00386439742521717,0.000119754877745343,0.007609039972689,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD011575_pub3_data","19::overall",19,"overall","Serious cardioavascular adverse events (excluding JATOS)",3,0.313423965207536,0.137219833860787,0.489628096554285,0.0220489484132033,-0.0126703971344354,0.0567682939608419,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011575_pub3_data","21::overall",21,"overall","Cardiovascular mortality (excluding JATOS)",3,0.45533343157842,0.0229936715101475,0.887673191646693,0.018129674329366,-0.0202652237133297,0.0565245723720616,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011575_pub3_data","3::overall",3,"overall","Serious cardiovascular adverse events",4,0.238345928718493,0.0133588932303047,0.463332964206682,0.00741403711656956,-0.000758613835102744,0.0155866880682419,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011575_pub3_data","5::overall",5,"overall","Non-cardiovascular mortality",4,0.0183077923316055,-0.336236110614344,0.372851695277555,-0.000795976710667852,-0.00524878684040963,0.00365683341907392,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD011600_pub3_data","27::overall",27,"overall","Death, COPD-related",2,-0.516406130787442,-1.00236416232027,-0.0304480992546182,-0.00291007230665563,-0.00585504750832266,3.49028950113921e-05,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD011626_pub3_data","7::overall",7,"overall","Adverse events",11,0.868656288291068,-0.0755242206662611,1.8128367972484,0.0463229249541619,0.0166015306211622,0.0760443192871615,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD011627_pub3_data","1::3",1,"3","Number of participants with incontinence-associated dermatitis",4,-1.16216246026579,-3.14744669459275,0.823121774061179,-0.151972651773446,-0.252783106516719,-0.0511621970301729,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD011670_pub3_data","2::overall",2,"overall","Wound infection",8,-0.0274699304082876,-0.768151769754303,0.713211908937727,0.0173145975035861,-0.0609329766100125,0.0955621716171846,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011670_pub3_data","3::overall",3,"overall","Abdominal abscess",5,-1.32757081549354,-2.50553030746796,-0.149611323519122,-0.0688903800760823,-0.157420312339692,0.0196395521875276,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011689_pub4_data","1::2",1,"2","Death",11,-0.0323658267474651,-1.16657557243057,1.10184391893564,3.03786726956856e-06,-0.00379535601714339,0.00380143175168253,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011689_pub4_data","1::overall",1,"overall","Death",51,0.0556949225079278,-0.451909332976631,0.563299177992487,-7.16282145595379e-05,-0.00107435742959776,0.000931101000478686,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011689_pub4_data","10::1",10,"1","Breastfeeding",10,0.0146526804010563,-0.0716832369211396,0.100988597723252,-0.00285441073581168,-0.014979661214904,0.00927083974328067,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD011689_pub4_data","10::overall",10,"overall","Breastfeeding",6,0.0110030472136493,-0.106425372254007,0.128431466681305,-0.00242822728841152,-0.0198425784129389,0.0149861238361159,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD011689_pub4_data","12::overall",12,"overall","Vomiting",101,0.337385532209211,0.110503742777828,0.564267321640594,0.00922786418233032,-0.00244820999938734,0.020903938364048,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011689_pub4_data","15::2",15,"2","Hypertension",3,-0.966857365234925,-2.22598915624806,0.292274425778214,-0.0464184044535596,-0.0837391953227065,-0.00909761358441283,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD011689_pub4_data","18::2",18,"2","Diarrhoea",5,1.06190562152344,0.244158146509765,1.87965309653712,0.00539675643396069,-0.000266578837457603,0.011060091705379,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD011689_pub4_data","2::1",2,"1","PPH >= 1000 mL",188,-0.0944765544866689,-0.177328715595582,-0.0116243933777559,-0.00143566544940996,-0.00348350011935954,0.000612169220539616,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011689_pub4_data","2::overall",2,"overall","PPH >= 1000 mL",107,-0.134392879520958,-0.251139107740132,-0.0176466513017843,-0.00211438765543855,-0.00505353966833104,0.000824764357453939,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011689_pub4_data","20::3",20,"3","Maternal satisfaction",6,0.0472545029630492,-0.0673247310093537,0.161833736935452,0.00776835593246569,0.00292458720508003,0.0126121246598514,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD011689_pub4_data","4::1",4,"1","Severe maternal morbidity: intensive care admissions",21,0.0753431322464351,-0.221426666523505,0.372112931016375,-4.20306436913345e-05,-0.000407596757491827,0.000323535470109158,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011689_pub4_data","4::overall",4,"overall","Severe maternal morbidity: intensive care admissions",12,0.0815797891268111,-0.330533815541149,0.493693393794771,-3.52797617222894e-05,-0.000550479470381483,0.000479919946936904,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011762_pub2_data","1::overall",1,"overall","All-cause mortality",206,-0.191018376366804,-0.305142116988093,-0.0768946357455157,0.000905834800751187,0.000404971128102233,0.00140669847340014,TRUE,TRUE,FALSE,"direction_only",TRUE,TRUE
"CD011762_pub2_data","11::overall",11,"overall","Fatal bleeding",90,-0.359452658593993,-0.758459936524211,0.0395546193362255,0.000303107243439858,-2.37158193279077e-05,0.000629930306207623,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011762_pub2_data","3::overall",3,"overall","Symptomatic VTE",245,-0.441696852959463,-0.537838514560488,-0.345555191358439,-0.000751154341132019,-0.00171648484474154,0.000214176162477506,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011762_pub2_data","4::overall",4,"overall","Major bleeding",291,-0.0317517982063819,-0.121431004958125,0.0579274085453613,0.00253000413336572,0.00142847537984463,0.00363153288688681,FALSE,TRUE,FALSE,"direction_and_significance",TRUE,TRUE
"CD011762_pub2_data","6::overall",6,"overall","Major bleeding: other direct factor Xa inhibitors (excluding rivaroxaban) versus LMWH",163,-0.298998769069644,-0.396820774733081,-0.201176763406207,0.000952589830967318,-0.000320523309068512,0.00222570297100315,TRUE,FALSE,FALSE,"direction_and_significance",TRUE,TRUE
"CD011762_pub2_data","8::overall",8,"overall","Serious non-hepatic adverse events",131,-0.184539421798777,-0.246183840866675,-0.12289500273088,0.000402470338898898,0.000128435330640469,0.000676505347157327,TRUE,TRUE,FALSE,"direction_only",TRUE,FALSE
"CD011762_pub2_data","9::overall",9,"overall","Fatal VTE",140,-0.440164638389827,-0.556941825046758,-0.323387451732896,-0.000322678138980312,-0.00133849983916083,0.00069314356120021,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011793_pub3_data","1::overall",1,"overall","Mortality",10,-0.129149390380807,-0.982702931238772,0.724404150477159,0.00029311626377993,-0.017687920598779,0.0182741531263389,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD011806_pub2_data","3::overall",3,"overall","Clinical relapse (mixed IBD) – sensitivity analysis (fixed-effect)",7,-0.653892713379348,-1.27215148285916,-0.0356339438995401,-0.120026605509693,-0.246975412994403,0.00692220197501586,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD011841_pub3_data","1::overall",1,"overall","Mean change in BCVA between baseline and 12 months (± 6)",32,-0.413252732105548,-0.998582940900431,0.172077476689335,0.0698079324065766,-0.374864257430579,0.514480122243733,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011858_pub2_data","4::overall",4,"overall","Death (any cause)",5,-0.0277969665835258,-1.03686050570727,0.981266572540215,0.00145243948638737,-0.0266557201639703,0.029560599136745,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD011858_pub2_data","6::overall",6,"overall","Activated partial thromboplastin time",4,0.0469976973911156,-1.58491641050369,1.67891180528592,-0.000924176819715309,-0.0231464075690312,0.0212980539296006,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011858_pub2_data","7::overall",7,"overall","Platelet count",3,0.499287189351445,-1.49047967297586,2.48905405167875,-7.58758237946579e-05,-0.0224811863852548,0.0223294347376655,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011858_pub2_data","8::overall",8,"overall","Potassium",3,-0.0536182902448799,-1.79054667314666,1.6833100926569,0.00566794987057296,-0.00920455916878905,0.020540458909935,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD011866_pub3_data","5::overall",5,"overall","Continuous abstinence, longest follow-up",9,0.55804630332189,-0.0573565405791392,1.17344914722292,0.141009493705331,0.0141174988144964,0.267901488596165,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD011885_pub2_data","44::overall",44,"overall","Adverse effects: insomnia",3,-0.0742919994157811,-1.78228066456596,1.6336966657344,8.74944980871033e-05,-0.0908472321620093,0.0910222211581835,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD012067_pub3_data","13::overall",13,"overall","Spot urine osmolality [mOsm/kg]",16,0.563910905079126,0.197907300060923,0.929914510097329,0.0416815336431043,-0.00888218345508616,0.0922452507412948,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD012067_pub3_data","15::overall",15,"overall","Serious adverse events",7,0.0681440409307771,-0.374261920060792,0.510550001922346,-0.00181392549603588,-0.0472026981944,0.0435748472023283,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012067_pub3_data","23::overall",23,"overall","Adverse events",25,0.871414943502289,0.229902248591936,1.51292763841264,0.0776262956595163,-0.00256376516008312,0.157816356479116,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD012067_pub3_data","5::overall",5,"overall","Death",29,-0.0772341865076233,-0.551443156299644,0.396974783284398,0.00375482453563974,-0.005826146912362,0.0133357959836415,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012067_pub3_data","8::overall",8,"overall","Diastolic blood pressure [mm Hg]",17,-0.0514347169492515,-0.432385304248825,0.329515870350322,0.0517920943309005,-0.0333383888897363,0.136922577551537,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012079_pub2_data","12::overall",12,"overall","Painful intercourse - de novo dyspareunia ",19,0.33182765743787,-0.175996901160453,0.839652216036192,0.032651022564682,0.0123917030697334,0.0529103420596307,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD012079_pub2_data","5::overall",5,"overall","Recurrent prolapse on examination (posterior compartment) ",7,0.0160998309585344,-0.687607005430575,0.719806667347644,-0.00894713244435135,-0.054922040006511,0.0370277751178083,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD012152_pub4_data","17::overall",17,"overall","Neonatal seizures",2,-0.350689289170142,-2.61655313974479,1.91517456140451,5.07791569265574e-06,-0.00361405800831605,0.00362421383970136,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD012152_pub4_data","26::overall",26,"overall","Developmental delay/intellectual impairment at six to seven years of age",2,-0.914468133708683,-1.95708479288279,0.12814852546542,-0.0867052443513885,-0.1425879770352,-0.0308225116675767,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD012186_pub2_data","1::overall",1,"overall","SAEs",91,0.0112301123855269,-0.0556903822795576,0.0781506070506113,0.0056856309852699,0.000265400725780735,0.0111058612447591,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012214_pub3_data","4::overall",4,"overall","Abnormal uterine bleeding",4,-0.217569067969066,-1.2998435896798,0.864705453741671,0.00508375873975556,-0.0939428541392645,0.104110371618776,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012397_pub2_data","7::overall",7,"overall","Specific behaviours: aggression, other episode of aggression (incidents per treatment days)",6,0.00999689022699142,-1.00916415617342,1.02915793662741,-0.00546415152468035,-0.0220282508804229,0.0110999478310622,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012429_pub2_data","1::overall",1,"overall","Change in mental state (BPRS)",16,-0.148856740022046,-0.619733888703576,0.322020408659484,0.0175062606168759,-0.0373160805680365,0.0723286018017883,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012429_pub2_data","10::overall",10,"overall","Akathisia",4,-0.707567918772771,-1.48729058583926,0.0721547482937223,-0.0990279640898162,-0.195765322300698,-0.00229060587893404,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD012429_pub2_data","14::overall",14,"overall","Tremor",3,-1.83673170573121,-3.41919963911859,-0.254263772343829,-0.0544094208615337,-0.112821235599564,0.00400239387649701,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD012429_pub2_data","22::overall",22,"overall","Toothache",3,-0.142657126508819,-1.81284387957987,1.52752962656223,0.0131370717274816,-0.00627856716598077,0.032552710620944,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD012503_pub3_data","2::1",2,"1","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on unilateral or bilateral limb RIC intervention)",36,0.0595779007413067,-0.0756661302133858,0.194821931695999,-0.00697665309962445,-0.0202111827528762,0.00625787655362732,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012503_pub3_data","4::1",4,"1","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on RIC intervention timing)",39,0.0598548390362853,-0.0677701041219677,0.187479782194538,-0.00827186929862411,-0.0221497473108296,0.00560600871358134,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012503_pub3_data","4::2",4,"2","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on RIC intervention timing)",11,0.228755519837376,0.0858603128753741,0.371650726799377,0.0131687262149808,-0.0160055209279348,0.0423429733578965,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD012503_pub3_data","5::1",5,"1","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on the duration of RIC intervention)",39,0.0380360869996252,-0.0924241837440559,0.168496357743306,-0.00805366805420445,-0.0210959127127803,0.00498857660437138,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012503_pub3_data","5::2",5,"2","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on the duration of RIC intervention)",12,0.260644234951404,0.121624191057738,0.39966427884507,0.041899961640965,-0.0301322911269109,0.113932214408841,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD012586_pub2_data","2::1",2,"1","OHSS",78,-0.103337691902896,-0.255757978052273,0.0490825942464811,-0.00610671184980435,-0.0103931698535006,-0.00182025384610813,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012586_pub2_data","4::2",4,"2","Multiple pregnancy",5,-0.00206580679766546,-0.561498415559696,0.557366801964365,0.00394583440937904,-0.0370866839425299,0.044978352761288,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012609_pub2_data","3::overall",3,"overall","Loss of clinical response in patients with exclusively fistulating disease",5,0.135126005808459,-1.77331483116377,2.04356684278069,-0.00532956640901648,-0.177515319689071,0.166856186871038,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD012635_pub2_data","2::1",2,"1","All-cause mortality at 24 hours ",2,-0.11578648787948,-1.50797584531188,1.27640286955292,0.00521288944809583,-0.0952692598918427,0.105695038788034,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD012635_pub2_data","6::overall",6,"overall","Venous thromboembolic events in the first 30 days after injury",3,0.0176536122453024,-0.725828639917459,0.761135864408064,-0.00988292622437542,-0.0418767703949353,0.0221109179461844,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD012635_pub2_data","8::1",8,"1","Arterial thromboembolic events in the first 30 days after injury",2,0.0153034675148602,-0.524782493832415,0.555389428862135,-0.00188785876325321,-0.0262625276857552,0.0224868101592488,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD012642_pub2_data","1::overall",1,"overall","Mortality (latest time reported up to hospital discharge)",21,-0.0750312627538696,-0.54902930076706,0.398966775259321,-0.0644521499939139,-0.118385826407274,-0.0105184735805534,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012642_pub2_data","6::overall",6,"overall","Bronchopulmonary dysplasia (≥ 28 days age)",4,0.706441243735247,-0.105436288753463,1.51831877622396,0.19402385505069,0.000366936069985918,0.387680774031393,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD012693_pub3_data","11::overall",11,"overall","Cycle cancellations for poor response",26,-0.378273452348966,-0.792333174324599,0.0357862696266659,-0.0275934838629843,-0.0546512814686605,-0.000535686257308057,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012693_pub3_data","29::overall",29,"overall","Dose-response: women with at least one transferable embryo",10,0.501563958686381,0.023377250596145,0.979750666776618,0.067716917961699,-0.00131842444572351,0.136752260369121,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD012712_pub2_data","1::overall",1,"overall","Mortality before hospital discharge",59,0.159945391087405,-0.0556050551205991,0.375495837295409,0.00529252143417417,0.000310731046707367,0.010274311821641,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012712_pub2_data","14::overall",14,"overall","Spontaneous intestinal perforation",12,0.0859029242731285,-0.279162273375146,0.450968121921403,-0.00196634951236367,-0.0297261146670629,0.0257934156423355,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012712_pub2_data","17::overall",17,"overall","Periventricular leukomalacia",9,-0.243340683935556,-0.467900469929919,-0.0187808979411919,-0.0214262996748088,-0.0453845781343113,0.00253197878469372,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD012712_pub2_data","6::overall",6,"overall","Duration of oxygen therapy, days",40,-0.218411160476181,-0.397757175933853,-0.0390651450185093,-0.00493971672605112,-0.0175221826320417,0.00764274917993949,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD012757_pub2_data","8::overall",8,"overall","Tumour response measures after treatment (partial response)",2,0.700727847792009,0.0467298766320338,1.35472581895198,0.153386831314034,-0.0063234601573183,0.313097122785387,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD012850_pub2_data","1::overall",1,"overall","Self-reported joint pain at rest (dichotomous data)",6,-0.080004173656858,-1.35038250192273,1.19037415460901,0.024925383934538,-0.233697000008378,0.283547767877454,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012850_pub2_data","20::overall",20,"overall","Frequency of joint noise",4,-1.56893159554588,-3.25229720236406,0.114434011272294,-0.346666666666667,-0.49333694107797,-0.199996392255363,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012850_pub2_data","5::overall",5,"overall","Self-reported joint pain at mastication (dichotomous data)",4,0.757347320082027,-0.00532684391639093,1.52002148408044,0.14953450336274,0.00287908891709501,0.296189917808386,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012850_pub2_data","6::overall",6,"overall","Muscle pain at rest (dichotomous data)",5,-0.007613361180345,-1.21186618258129,1.1966394602206,0.0653121233344932,-0.274895934306154,0.40552018097514,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012891_pub2_data","7::overall",7,"overall","Clinical pregnancy",7,0.558406006945085,0.0417644262982488,1.07504758759192,0.0138622675008681,-0.0205281544958108,0.048252689497547,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD012905_pub2_data","1::overall",1,"overall","Development of AKI",24,-0.306565511731597,-0.570526066100705,-0.0426049573624883,-0.0502033126346699,-0.100513503927434,0.000106878658094299,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD012905_pub2_data","2::overall",2,"overall","Need for kidney replacement therapy",20,-0.218824535175179,-0.585771491832818,0.148122421482461,-0.019427568627622,-0.0388250800286259,-3.00572266179813e-05,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD012905_pub2_data","3::overall",3,"overall","Death",16,0.138275212644163,-0.125995925225763,0.40254635051409,-0.00274947045909246,-0.0365272493715817,0.0310283084533968,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012905_pub2_data","6::overall",6,"overall","Duration of ICU stay [days]",7,0.981437990385479,0.0215234941765455,1.94135248659441,0.090176592797784,-0.0805927301634654,0.260945915759033,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD012905_pub2_data","8::overall",8,"overall","Sensitivity analysis: development of AKI based on risk of attrition bias",8,-0.470637608297703,-0.903900333063081,-0.0373748835323252,-0.0599633218905294,-0.142412804069126,0.0224861602880677,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD012925_pub2_data","6::overall",6,"overall","Client utilisation of primary healthcare and/or services (risk ratio)",9,0.00733311061160457,-0.329685555086037,0.344351776309246,-0.0110103640631667,-0.0493979401453861,0.0273772120190526,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012942_pub2_data","10::overall",10,"overall","Comparison 10 Vortioxetine versus placebo, Outcome 2 Acceptability",6,0.325132809345782,0.0620748032050916,0.588190815486472,0.0230806324484442,-0.00501626031679752,0.0511775252136859,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD012993_pub2_data","3::overall",3,"overall","Infusion reactions",4,0.00633810223089675,-0.90767932124038,0.920355525702173,-0.139029820261438,-0.552974031270155,0.274914390747279,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD012993_pub2_data","8::overall",8,"overall","Treatment-emergent adverse events (breakdown 1)",6,-0.243169062123965,-0.705481163812565,0.219143039564634,0.00218853491707707,-0.034132894462688,0.0385099642968421,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013023_pub2_data","2::overall",2,"overall","Dislodgement",15,-0.671323466141231,-1.26169799012274,-0.080948942159719,-0.0280215520853805,-0.0621560162029681,0.00611291203220704,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013023_pub2_data","4::overall",4,"overall","Adverse events",10,-0.213995598447762,-0.580602756882637,0.152611559987112,0.00363909058615293,-0.0248968180182397,0.0321749991905456,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013042_pub2_data","5::overall",5,"overall","Proportion of overall withdrawals",39,-0.123389162613443,-0.398388877612688,0.151610552385803,0.033302406640188,-0.0627238995599737,0.12932871284035,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013051_pub3_data","2::2",2,"2","Subgroup analysis: CSOM diagnosis",2,1.68152916330714,0.669895080886357,2.69316324572792,0.187644833977192,-0.0358904413431335,0.411180109297518,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013052_pub3_data","3::2",3,"2","Subgroup analysis: CSOM diagnosis",6,-0.0676360338486207,-0.51586629623815,0.380594228540909,0.00576246372102791,-0.0503822552726356,0.0619071827146914,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013055_pub3_data","2::overall",2,"overall","Resolution of ear discharge (after 4 weeks)",2,-0.396433195670723,-3.62363624619921,2.83076985485777,0.0645489201037835,-0.250008894595933,0.3791067348035,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013059_pub2_data","2::overall",2,"overall","Treatment non-acceptability",37,0.238009754192388,-0.35006443322439,0.826083941609166,0.081916371994725,0.0258647450174797,0.13796799897197,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013071_pub2_data","11::overall",11,"overall","Cardiovascular mortality (subgroup: age and testosterone level)",10,-0.106240990658999,-1.19086317965224,0.978381198334246,0.00107724902829346,-0.00520838504700302,0.00736288310358995,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013071_pub2_data","15::overall",15,"overall","Cardiovascular mortality (subgroup: metabolic syndrome (MS))",10,-0.106240990658999,-1.19086317965225,0.978381198334246,0.00107724902829346,-0.00520838504700302,0.00736288310358995,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013071_pub2_data","2::overall",2,"overall","Erectile function (IIEF)",18,0.00181905441002805,-0.676288671603088,0.679926780423144,-0.0114530911857223,-0.164866358602419,0.141960176230974,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013071_pub2_data","5::overall",5,"overall","Sexual quality of life (IIEF-overall satisfaction)",7,-0.00293319459167807,-0.924165105975201,0.918298716791845,0.01671009501141,-0.0208733145048777,0.0542935045276976,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013105_pub2_data","1::1",1,"1","Bladder function ",11,-0.434231168066537,-0.890795677517514,0.02233334138444,-0.0479553025040729,-0.0824136723705559,-0.01349693263759,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013111_pub2_data","1::overall",1,"overall","Metformin plus progestin compared to progestin. Live birth rate. RCTs",4,0.79410803439035,0.0663020681945539,1.52191400058615,0.143803328252941,-0.00862438932831489,0.296231045834197,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD013197_pub2_data","5::overall",5,"overall","Serious adverse events (SAEs) short-term",16,-0.0860046921900881,-0.555894487112604,0.383885102732428,1.65916661131205e-05,-0.0177274681939389,0.0177606515261652,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013232_pub2_data","1::overall",1,"overall","Irritability",84,-0.0141185523737285,-0.443745705763491,0.415508601016034,0.0635466340408015,-0.0201626799705496,0.147255948052152,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013232_pub2_data","10::overall",10,"overall","Adverse effects: metabolic (continuous)",46,0.164869113426498,-0.0949455836210032,0.424683810473998,0.0150073370653463,0.00463130339924769,0.0253833707314449,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013232_pub2_data","14::overall",14,"overall","Adverse effects: respiratory",72,0.195296706739857,-0.00180344793223267,0.392396861411946,0.0182008365664648,0.00754371721130971,0.0288579559216199,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013232_pub2_data","8::overall",8,"overall","Adverse effects: immune system",166,0.0516598215490113,-0.0881261109269516,0.191445754024974,0.0168183471558741,0.00555450030731277,0.0280821940044354,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013255_pub2_data","4::overall",4,"overall","30-day cardiovascular mortality",12,-0.110680216786482,-1.13673605826589,0.915375624692929,0.00655899062912791,-0.00326321684837556,0.0163811981066314,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013255_pub2_data","5::overall",5,"overall","Stroke or systemic embolism at 30 days",10,-0.0818189370215598,-1.23477865680182,1.0711407827587,0.0059910481430341,-0.00325717329487197,0.0152392695809402,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013278_pub3_data","10::1",10,"1","Intraventricular hemorrhage (IVH; grades I to IV)",4,0.235473400605826,-1.03291937740329,1.50386617861494,-0.0377415234807361,-0.178358812703157,0.102875765741685,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013278_pub3_data","12::2",12,"2","Periventricular leukomalacia (PVL; any grade)",2,-0.0286322569548509,-1.07263172717844,1.01536721326874,0.00393005002950707,-0.0785347542884243,0.0863948543474384,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD013278_pub3_data","5::1",5,"1","Chronic lung disease (CLD)",3,-0.530585902745881,-1.09482902922467,0.033657223732908,-0.10763128515741,-0.215092164476891,-0.000170405837928711,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013278_pub3_data","5::3",5,"3","Receipt of rescue medical treatment for a hs-PDA",2,-1.40365107720791,-2.68041687676072,-0.126885277655103,-0.241896352166505,-0.637373328594785,0.153580624261776,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013303_pub2_data","5::overall",5,"overall","Health outcomes: subjective health status (short-term: immediately post-intervention)",8,0.685932039733889,0.246964586331193,1.12489949313659,0.141928592675724,-0.0128312710260865,0.296688456377535,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013332_pub2_data","2::overall",2,"overall","All-cause mortality",22,-0.250201753454489,-0.497517320047233,-0.00288618686174522,-0.00538635408104541,-0.0119880399048939,0.00121533174280309,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD013342_pub2_data","8::overall",8,"overall","Withdrawals due to adverse events",8,-0.147410132932788,-1.15351810009099,0.858697834225417,0.0191995651094235,-0.0333878801690911,0.0717870103879381,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013344_pub2_data","6::overall",6,"overall","BK viruria",6,-0.0755660688803466,-0.670256222575178,0.519124084814485,0.016808388185812,-0.000439197208708809,0.0340559735803328,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013355_pub2_data","3::overall",3,"overall","Haemodynamic outcome: arterial hypotension",2,0.4816545028738,-0.327395056212268,1.29070406195987,0.0284831902936261,0.00196438723618229,0.05500199335107,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013366_pub2_data","1::overall",1,"overall","Venous thromboembolism",13,-0.589822656971029,-1.1115604989405,-0.0680848150015563,-0.00504073439379699,-0.0136937687471917,0.00361229995959769,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD013366_pub2_data","2::overall",2,"overall","Venous thromboembolism (subgroup analysis - age)",22,-0.164390104397035,-0.383522982617584,0.054742773823513,0.00436719986323987,-0.00629471553811929,0.015029115264599,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013366_pub2_data","4::overall",4,"overall","PICC-associated BSI",14,-0.563327910129308,-1.00176592874205,-0.124889891516566,-0.0446085386145543,-0.0919149049530042,0.00269782772389565,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013366_pub2_data","5::overall",5,"overall","Occlusion",16,-0.488718495286161,-0.897686343480545,-0.079750647091777,-0.0328047941112949,-0.0688743211279393,0.00326473290534945,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013377_pub2_data","1::overall",1,"overall","Overall survival",9,1.46920368119726,0.916343380971904,2.02206398142262,0.240529810915212,-0.265153094555776,0.7462127163862,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013377_pub2_data","2::overall",2,"overall","Progression-free survival ",8,0.203076543542654,-0.273252568414653,0.679405655499961,-0.0136595833701114,-0.0677270567718009,0.0404078900315781,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013396_pub2_data","4::5",4,"5","Adverse events",4,-0.908434913530091,-1.88634433900813,0.0694745119479449,-0.00849426572622466,-0.0167052690520336,-0.000283262400415761,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD013396_pub2_data","7::overall",7,"overall","Upper respiratory tract infection",9,-0.00282357335470104,-0.150568234744793,0.144921088035391,0.00346866565186202,-0.0139448753086914,0.0208822066124154,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD013408_pub2_data","1::overall",1,"overall","All-cause mortality",5,-0.482067250149651,-0.858375404448387,-0.105759095850914,-0.0265513132509464,-0.0551107633284001,0.00200813682650728,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013408_pub2_data","13::overall",13,"overall","Major cerebrovascular bleeding events",3,0.229661808204711,-0.252610051269656,0.711933667679079,-0.00133106976864168,-0.00440473235163639,0.00174259281435303,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013408_pub2_data","9::overall",9,"overall","AF-related emergency department visits",2,-0.633030172880905,-1.7092054656408,0.443145119878989,-0.015522212799409,-0.0269119444618414,-0.00413248113697665,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013414_pub2_data","12::overall",12,"overall","Vitamin B12 deficiency",2,0.908219243529396,0.170142546574154,1.64629594048464,0.0433953333971709,-0.0319963027468916,0.118786969541233,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD013414_pub2_data","5::overall",5,"overall","Kidney failure",7,-0.0699596874475092,-0.230371838043435,0.0904524631484166,0.000901414306739335,-0.00733653908220085,0.00913936769567952,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013425_pub2_data","7::overall",7,"overall","Quality of life: clinically important change in quality of life (≥ 20% increase in QLS endpoint score)",10,1.06164932492176,0.274873596713805,1.84842505312972,0.133995838629191,-2.03068789463301e-05,0.268011984137329,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD013445_pub2_data","2::overall",2,"overall","Major complications",34,-0.172783851199667,-0.561540030496983,0.215972328097649,0.000968570794945936,-0.0224212278662055,0.0243583694560974,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013445_pub2_data","23::overall",23,"overall","Subgroup analysis by stone size: major complications",25,-0.165404385986063,-0.664912634559729,0.334103862587603,0.000567243009077682,-0.0302656084653151,0.0314000944834705,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013445_pub2_data","34::overall",34,"overall","Sensitivity analysis for secondary interventions by definition of stone freedom (≤ 4 mm by any imaging modality)",9,-0.905382168662513,-1.51331138086375,-0.297452956461272,-0.0865878964109879,-0.17985659987906,0.00668080705708474,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD013456_pub2_data","6::overall",6,"overall","Psychosocial interventions versus inactive control; outcome 4: Adverse events",11,0.257052483996721,-0.792433301153394,1.30653826914684,0.0384636900383405,0.000451764355005921,0.0764756157216751,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013462_pub3_data","3::overall",3,"overall","Rate of surgical reintervention",12,0.246790927202314,-0.254825300588938,0.748407154993566,-0.00533685834823688,-0.0153081540118794,0.00463443731540566,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013476_pub2_data","13::overall",13,"overall","Asthma exacerbations after 6 months follow-up",2,-1.00319178267302,-2.01040234467686,0.00401877933082884,-0.228698593955469,-0.448599989325266,-0.00879719858567321,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013476_pub2_data","6::overall",6,"overall","Significant adverse events during maintenance therapy up to 6 months follow-up",4,1.15108355855598,-0.500908921819861,2.80307603893182,0.0811383195204096,0.013517614831855,0.148759024208964,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013539_pub2_data","11::overall",11,"overall","Any adverse events",15,0.0361739822048128,-0.108038225763575,0.180386190173201,0.0103341055015968,0.00163248697479966,0.019035724028394,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013539_pub2_data","7::overall",7,"overall","Neutralising antibodies",27,-0.20634076649935,-0.421983853180956,0.00930232018225596,-0.00377306568100142,-0.00664952307773045,-0.000896608284272395,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013539_pub2_data","8::overall",8,"overall","Antidrug antibodies",57,-0.00544673462313235,-0.144474876662671,0.133581407416406,0.000284535233691411,-0.00259932817183038,0.0031683986392132,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013539_pub2_data","9::overall",9,"overall","Any adverse events",43,-0.00501137175435236,-0.181619848351792,0.171597104843087,0.000698189907426453,-0.00233707387531045,0.00373345369016335,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013541_pub2_data","1::overall",1,"overall","Relapse (≤ 1 month postintervention)",61,-0.331513741757019,-0.61556293272233,-0.0474645507917084,-0.032812437055766,-0.07687034670673,0.011245472595198,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013541_pub2_data","3::overall",3,"overall","Relapse (> 6 months postintervention)",28,-0.294507655486939,-0.664586170773333,0.075570859799455,-0.0451418418487934,-0.0902137151398904,-6.99685576964065e-05,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013561_pub2_data","2::overall",2,"overall","Biochemical remission according to normalisation of IGF-1 and GH",8,0.713938130484974,-0.0562942409637575,1.4841705019337,0.170451732383516,0.0194693245748715,0.32143414019216,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013590_pub2_data","4::overall",4,"overall","SCD-related complications (number of participants)",16,0.400447180921498,-0.235498177702271,1.03639253954527,0.0404503486801235,0.0039210888729973,0.0769796084872497,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013595_pub2_data","7::overall",7,"overall","Lymphopenia",3,0.32870407690162,0.0323585998294746,0.625049553973764,0.039991780078438,-0.0103191918281414,0.0903027519850174,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013614_pub2_data","16::1",16,"1","Withdrawal due to adverse events",11,0.338180478289242,-0.103864278234725,0.780225234813209,0.0132277902684417,0.000344067687754187,0.0261115128491292,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013614_pub2_data","16::3",16,"3","Withdrawal due to adverse events",4,-0.222251126524375,-1.67968605747162,1.23518380442287,0.00156842413951476,-0.024285084135406,0.0274219324144355,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013614_pub2_data","25::2",25,"2","Resolution of dactylitis as no dactylitis at 52 weeks",3,-0.20028068559308,-0.400546471798183,-1.48993879772463e-05,-0.0187286236134775,-0.100237587141148,0.0627803399141932,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013614_pub2_data","3::1",3,"1","Disease activity as measured by MDA-PsA criteria or by DAS 28 or by DAS at 12 weeks",10,0.564165969173663,-0.0597724712801007,1.18810440962743,0.0877043610987021,0.00111533898504837,0.174293383212356,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD013614_pub2_data","34::1",34,"1","Resolution of dactylitis as no dactylitis at 24 weeks",3,-0.0374346800375489,-0.522435187302059,0.447565827226961,0.00569991799816089,-0.0682502929850274,0.0796501289813491,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD013631_pub2_data","13::overall",13,"overall","Withdrawals due to adverse events",9,0.157812183620405,-0.57527926623421,0.890903633475019,0.0636700760886381,0.00592953070587764,0.121410621471399,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013643_pub2_data","14::2",14,"2","Number of minor adverse events (Clavien-Dindo I, II), short term (< 1 year) ",4,1.19423462879618,-1.77433913795325,4.16280839554562,-0.0161912070428893,-0.076850212405987,0.0444677983202085,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013672_pub2_data","3::2",3,"2","Treatment retention, subgroup analysis: single provider primary care setting versus availability of a primary care team",8,0.655200490301867,-0.052781517441971,1.36318249804571,0.140256208942558,0.00361513154795748,0.276897286337159,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013707_pub2_data","11::overall",11,"overall","Renal failure requiring replacement therapy",2,0.162993723232163,-1.79612167910161,2.12210912556594,-0.00745326679606426,-0.0972500500896109,0.0823435164974824,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013715_pub2_data","12::overall",12,"overall","Withdrawals due to adverse events at 17 to 26 weeks",3,-1.50478097290391,-3.40098958469322,0.391427638885407,-0.0796457554941692,-0.151866862295423,-0.00742464869291597,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013715_pub2_data","13::overall",13,"overall","Withdrawals due to adverse events at 27 to 52 weeks",4,1.34573292085751,0.35563254112993,2.33583330058509,0.203036406784967,-0.0496600287728197,0.455732842342754,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013715_pub2_data","14::overall",14,"overall","Withdrawals due to adverse events at end of study",7,0.78939348658495,-0.199271060782953,1.77805803395285,0.0712822790564421,0.0017423815744672,0.140822176538417,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013715_pub2_data","15::overall",15,"overall","Serious adverse events at up to 16 weeks",4,1.58945834550521,0.113808583369819,3.0651081076406,0.128941304058646,-0.075887228334737,0.333769836452029,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013745_pub2_data","1::overall",1,"overall","Rivaroxaban versus antiplatelet therapy",9,0.279073733595363,0.0281581225312312,0.529989344659495,0.00363468738750899,-0.00330163239184991,0.0105710071668679,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013748_pub2_data","2::overall",2,"overall","Case fatality",16,-0.331512175095137,-0.730580386770903,0.0675560365806296,-0.0427330020641296,-0.0814133697365251,-0.00405263439173401,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD013748_pub2_data","7::overall",7,"overall","Hydrocephalus",12,-0.455160145404403,-1.02736758726309,0.117047296454282,-0.100833239295597,-0.181656652308209,-0.0200098262829852,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013758_pub2_data","10::overall",10,"overall","Obesity (formula with complementary foods): subgroup analysis by duration of treatment",11,0.443270012476174,-0.0307451522787838,0.917285177231133,0.00937816282442816,0.000402408848385914,0.0183539168004704,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013764_pub2_data","3::overall",3,"overall","Blood transfusion",3,0.000504156383803578,-1.72748784510511,1.72849615787272,-0.00133353219196487,-0.00516431549378576,0.00249725110985602,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013764_pub2_data","6::overall",6,"overall","Adherence",2,-0.531496418394586,-0.794223476445608,-0.268769360343563,-0.0630726316396297,-0.166360019463609,0.04021475618435,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013781_pub2_data","11::overall",11,"overall","Secondary outcome: proportion of weaning failure within 48 hours of extubation",27,0.597182391839146,0.0445779160290493,1.14978686764924,0.142840021964682,-0.0361029501976678,0.321782994127033,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013781_pub2_data","19::overall",19,"overall","Secondary outcome: number of participants requiring additional inotropic drugs - dobutamine",5,-0.976050940168384,-2.04316828111147,0.0910664007746969,-0.189763270302231,-0.37616822306086,-0.00335831754360319,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD013781_pub2_data","22::overall",22,"overall","Secondary outcome: proportion of renal failure",4,-1.03739122521554,-1.91752485773884,-0.15725759269225,-0.187291251452957,-0.390490848535033,0.0159083456291193,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013781_pub2_data","4::overall",4,"overall","Secondary outcome: length of hospital stay (days)",39,-0.214412036394053,-0.471854587938436,0.0430305151503294,-0.0158542154824371,-0.0251771075442195,-0.0065313234206548,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013781_pub2_data","5::overall",5,"overall","Secondary outcome: mean arterial pressure (24 hours after surgery)",41,-0.139149753158268,-0.354302168880638,0.0760026625641024,-0.016495711848838,-0.0293517952308961,-0.00363962846677987,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013781_pub2_data","7::overall",7,"overall","Secondary outcome: number of participants requiring additional inotropic drugs - dopamine",17,-0.330234497568581,-1.14782330042699,0.487354305289826,-0.0953007155289112,-0.163907711929559,-0.0266937191282631,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013800_pub2_data","12::overall",12,"overall","Acute myocardial infarction",4,-0.107866654061649,-0.335235897982075,0.119502589858778,-0.0062815856548034,-0.00995652294829917,-0.00260664836130763,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013800_pub2_data","15::overall",15,"overall","Congestive heart failure",3,0.0799120944039535,-0.59343802852213,0.753262217330037,-0.00171640217338394,-0.0370671776506777,0.0336343733039098,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD013800_pub2_data","5::overall",5,"overall","Loss of residual kidney function (number who became anuric) at approximately 12-month follow-up",3,-1.1968281629714,-1.58593116319868,-0.80772516274411,-0.163662387076993,-0.334737496259869,0.00741272210588242,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013800_pub2_data","6::overall",6,"overall","All-cause death",48,-0.195420298249235,-0.368585258931156,-0.0222553375673131,-0.0295070853898972,-0.0634780022895061,0.0044638315097118,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013800_pub2_data","7::overall",7,"overall","Cardiovascular death",24,-0.0151049795260128,-0.240938654051347,0.210728694999321,0.00281448601465172,-0.0181155012441804,0.0237444732734838,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013801_pub2_data","17::overall",17,"overall","Incidence of hypotension requiring vascular expansion",2,-1.67183859998943,-3.82800722459548,0.484330024616613,-0.0638300307098213,-0.122386138712267,-0.00527392270737527,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD013816_pub2_data","11::overall",11,"overall","Cardiac tamponade",4,-0.0416106967386,-1.62378904119825,1.54056764772105,0.0014687843622974,-0.0036466246728529,0.0065841933974477,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013816_pub2_data","15::overall",15,"overall","Adverse events - Bleeding (clinically significant bleeding that does not qualify as device-pocket hematoma, hemothorax, cardiac tamponade, or non-tamponade pericardial effusion)",4,0.00923446058393552,-0.831812935402429,0.8502818565703,-0.00248297434723806,-0.00819439196260202,0.00322844326812589,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013816_pub2_data","3::overall",3,"overall","Transient ischemic attack",6,-0.00572820837701255,-1.49275324795613,1.4812968312021,0.000174014003832555,-0.0151653442820351,0.0155133722897002,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013816_pub2_data","7::overall",7,"overall","Peripheral embolism",6,0.0618159043986094,-0.606141722871877,0.729773531669096,-2.14057633443412e-05,-0.0216053213783419,0.0215625098516532,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013823_pub2_data","4::overall",4,"overall","Preterm birth (< 37 weeks)",2,-0.0385459967830474,-0.706778802957169,0.629686809391074,0.00442988730216055,-0.0620983897385843,0.0709581643429054,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD013827_pub2_data","2::overall",2,"overall","Oocyte pick-up cancellation",12,-0.025747959658746,-0.304804954039908,0.253309034722416,0.00104127058393085,-0.0159809922188235,0.0180635333866852,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013830_pub2_data","11::2",11,"2","Patent ductus arteriosus (PDA) requiring any treatment",4,-0.698997504943471,-0.871775314232202,-0.526219695654739,-0.0719026356293085,-0.168562525807563,0.0247572545489456,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013830_pub2_data","12::2",12,"2","Patent ductus arteriosus (PDA) requiring ligation",4,-0.574383556891804,-1.24762246029561,0.0988553465119978,-0.081259391639511,-0.103622175949252,-0.0588966073297695,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013830_pub2_data","13::1",13,"1","Any intraventricular hemorrhage (IVH)",3,-0.955112874044131,-2.12461392181989,0.21438817373163,-0.127030803972642,-0.240054325819275,-0.0140072821260092,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD013830_pub2_data","16::1",16,"1","Necrotizing enterocolitis (NEC) (Bell's stage II or greater OR any grade; requiring surgery)",2,0.0504702261563602,-1.57537604624534,1.67631649855806,-0.0249187432286024,-0.0920163194085835,0.0421788329513787,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD013844_pub2_data","2::overall",2,"overall","Self-harm at short term (1-3 months) follow-up",4,-0.49486591813496,-0.967993301129582,-0.0217385351403365,-0.0137910718595442,-0.0408261852550854,0.013244041535997,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD013844_pub2_data","3::overall",3,"overall","Self-harm at medium-term (4-12 months) follow-up",14,0.0048297346149236,-0.47337019902494,0.483029668254787,-0.00648290480869901,-0.0112234436065754,-0.00174236601082264,FALSE,TRUE,FALSE,"direction_and_significance",TRUE,TRUE
"CD013844_pub2_data","6::overall",6,"overall","Suicidal ideation postintervention: sensitivity analysis (ICC 0.01)",18,-0.341463822696061,-0.604792972624188,-0.0781346727679326,-0.00465398736708861,-0.0121484620674578,0.00284048733328061,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD013853_pub2_data","6::overall",6,"overall","Exergaming vs control at the end of treatment: change in attention, processing speed, working memory",4,-1.02280222052412,-2.78747338544024,0.741868944392007,-0.171222222222222,-0.332818434987699,-0.00962600945674497,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD013874_pub3_data","2::overall",2,"overall","Time to relapse over 24 months",19,-0.284164128584576,-0.819168912661727,0.250840655492575,0.0129947728615662,-0.00965213880722142,0.0356416845303539,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD013875_pub2_data","2::overall",2,"overall","Live birth (or ongoing pregnancy) – all studies",8,0.598851159303747,-0.00162691425180417,1.1993292328593,0.0978920487185856,0.00552687181196723,0.190257225625204,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD013875_pub2_data","4::overall",4,"overall","Live birth (or ongoing pregnancy) – sensitivity analysis (live birth only)",5,0.205093832704241,-0.343575280137031,0.753762945545512,0.0632541601429094,0.00144921703225419,0.125059103253565,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD014089_data","11::overall",11,"overall","Adverse effects",6,0.624680671182923,0.0582815237149327,1.19107981865091,0.10073820958375,-0.00667243685890928,0.208148856026409,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014145_pub2_data","9::overall",9,"overall","Side effects causing cessation of therapy",2,1.88963776779391,-0.313393665467255,4.09266920105508,0.110047272720119,0.0149775796460214,0.205116965794217,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014300_pub2_data","13::overall",13,"overall","Acceptability at study endpoint: children",10,-0.0761672850425809,-0.650672293945535,0.498337723860373,0.00401299659421771,-0.0529015753440943,0.0609275685325298,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014541_pub2_data","13::overall",13,"overall","Major bleeding: short-term (45 days or fewer); same extended agent sensitivity analysis",3,0.90080576568107,0.427955048964137,1.373656482398,0.00391983857102299,-0.00161660274307127,0.00945627988511726,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014541_pub2_data","15::overall",15,"overall","Major bleeding: short-term (45 days or less); ≥ 75 years versus < 75 years of age subgroup analysis",6,0.503490843560148,0.088278456608362,0.918703230511934,0.0018403467801761,-0.000208588505090888,0.00388928206544309,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014541_pub2_data","3::overall",3,"overall","Symptomatic VTE: short-term (45 days or fewer); COVID-19 sensitivity analysis",3,-0.626474590760202,-1.26054678730313,0.00759760578272339,-0.00492634055150106,-0.00805923283512711,-0.00179344826787501,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD014544_pub2_data","4::overall",4,"overall","HRQoL—EQ-5D-5L VAS",27,0.439291867920713,-0.0723740100530618,0.950957745894489,0.0978436278766945,0.00659306090191003,0.189094194851479,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014585_pub2_data","3::4",3,"4","Adverse events",4,0.0172930436878386,-1.38559810260862,1.4201841899843,-0.0191899722451864,-0.148663947327187,0.110284002836814,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD014585_pub2_data","5::overall",5,"overall","Ulcer complications ",5,-1.0154411743203,-2.02790957629268,-0.00297277234791715,-0.00294011011080847,-0.00675272789016881,0.000872507668551864,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014594_pub2_data","1::overall",1,"overall","First-pass success",64,-0.10067802761839,-0.444595844369583,0.243239789132802,0.0205456726335507,-0.0134654998933302,0.0545568451604315,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014594_pub2_data","2::overall",2,"overall","Sensitivity analysis: first-pass success excluding rescue U/S",31,-0.274417611957242,-0.774995824006103,0.226160600091618,0.0083559578653462,-0.0392945789210031,0.0560064946516955,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014594_pub2_data","4::overall",4,"overall","Time to successful CFA access: sensitivity analysis from skin penetration",4,-1.05054732514651,-1.93957260136672,-0.161522048926305,-0.0206820364645578,-0.0534883707432627,0.0121242978141471,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014624_pub2_data","1::1",1,"1","Depression response (early phase)",8,0.538667421548954,0.112729825857169,0.964605017240738,0.0312847107645879,-0.0151530742249458,0.0777224957541217,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014624_pub2_data","3::2",3,"2","Adverse events (mother)",8,0.530176552123768,0.0283655033491206,1.03198760089842,0.0125326443986808,-0.00137932624308801,0.0264446150404496,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014666_pub2_data","2::overall",2,"overall","Fear of falling: subgrouped according to mean age",31,-0.0871968590135435,-0.585135780350343,0.410742062323256,0.00896114245995272,-0.161424443237805,0.179346728157711,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014678_pub2_data","3::overall",3,"overall","All-cause mortality (dabigatran versus placebo)",37,0.436364028194179,0.0760584419996119,0.796669614388746,0.00207667830939111,-0.000365580451901601,0.00451893707068382,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014678_pub2_data","5::overall",5,"overall","Stroke",34,-0.165027668527689,-0.373219691828713,0.0431643547733357,-0.00115429279636099,-0.00226591798210686,-4.26676106151174e-05,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014736_pub2_data","2::overall",2,"overall","Six-minute walk test (metres)",8,-0.0990947515154865,-0.820940098720234,0.622750595689261,0.0223328735418356,-0.0242091448791042,0.0688748919627755,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014741_pub2_data","2::overall",2,"overall","Myocardial infarction (fatal or non-fatal)",17,0.075036087634085,-0.301292715482707,0.451364890750877,-0.00625245952397162,-0.0127818140315994,0.000276894983656203,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD014741_pub2_data","6::overall",6,"overall","Adverse events (any infections)",28,-0.0942103333235199,-0.36036239233309,0.17194172568605,0.00306758161368471,-0.00235286153314369,0.00848802476051311,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014741_pub2_data","7::overall",7,"overall","Stroke (fatal or non-fatal)",7,-0.2042894999303,-1.13319407403831,0.724615074177708,0.00106664693851623,-0.00364929228896363,0.0057825861659961,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD014741_pub2_data","9::overall",9,"overall","Heart failure",7,-0.146900145021642,-0.880866785476648,0.587066495433364,0.00113164517221601,-0.00051775085662897,0.00278104120106099,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD014762_pub2_data","1::overall",1,"overall","Short-term resolution of symptoms (days 1 to 4 after randomisation)",6,-0.749081554463749,-1.37468066857913,-0.123482440348365,-0.155189243256213,-0.310573962082027,0.000195475569600895,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014763_pub2_data","3::overall",3,"overall","Participant satisfaction (unsatisfied or very unsatisfied)",9,-1.0941920302658,-2.27732098308477,0.0889369225531624,-0.140515643108377,-0.272917572367334,-0.00811371384941897,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014769_pub2_data","1::overall",1,"overall","Any VTE",27,-0.167274698918384,-0.328380954679016,-0.00616844315775197,-0.000924998172874607,-0.00201283207191435,0.00016283572616513,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","10::overall",10,"overall","Sensitivity analysis for any VTE excluding unpublished data",9,-0.26695736366533,-0.564652065935798,0.0307373386051376,-0.00210638940387619,-0.00394383886933325,-0.000268939938419125,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","12::overall",12,"overall","Sensitivity analysis for any VTE excluding data from  > 15% missing outcome data",11,-0.209569035555901,-0.450327825258421,0.0311897541466191,-0.00155171790921663,-0.00296510744269102,-0.000138328375742228,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","13::overall",13,"overall","Subgroup analysis for DVT stratified by type of statin",6,-0.363603197133642,-0.890896143601237,0.163689749333952,-0.00188133431536557,-0.00302223123524194,-0.000740437395489199,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","16::overall",16,"overall","Subgroup analysis for any serious adverse event stratified by type of statin",13,-0.0517943421310546,-0.0978911829597209,-0.0056975013023883,-0.00064683854826871,-0.00491645703755468,0.00362277994101726,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014769_pub2_data","2::overall",2,"overall","Subgroup analysis for any VTE stratified by provoked status",27,-0.167274698918384,-0.328380954679016,-0.00616844315775208,-0.000924998172874607,-0.00201283207191434,0.000162835726165131,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","24::overall",24,"overall","Sensitivity analysis for hepatic disorders",19,0.113224349637353,-0.0256219609484958,0.252070660223203,0.00209802573935414,0.000225553463605625,0.00397049801510266,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","4::overall",4,"overall","Subgroup analysis for any VTE stratified by sex",2,-0.565423274009732,-0.98892952470684,-0.141917023312624,-0.00263847942888921,-0.00528866608585464,1.17072280762182e-05,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014769_pub2_data","5::overall",5,"overall","Subgroup analysis for any VTE stratified by disease",27,-0.167274698918384,-0.328380954679016,-0.00616844315775203,-0.000924998172874607,-0.00201283207191434,0.00016283572616513,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","6::overall",6,"overall","Subgroup analysis for any VTE stratified by type of statin",27,-0.167274698918384,-0.328380954679016,-0.00616844315775203,-0.000924998172874607,-0.00201283207191435,0.00016283572616513,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","7::overall",7,"overall","Subgroup analysis for any VTE statified by different doses of rosuvstatin",9,-0.442123200288515,-0.691611059196681,-0.192635341380349,-0.00166087376279057,-0.00341945905147122,9.77115258900851e-05,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014769_pub2_data","9::overall",9,"overall","Subgroup analysis for any VTE stratified by treatment duration",27,-0.167274698918384,-0.328380954679016,-0.00616844315775197,-0.000924998172874607,-0.00201283207191434,0.00016283572616513,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014792_pub2_data","1::overall",1,"overall","Mortality (Grade V Clavien-Dindo)",6,0.0794082768379773,-0.421230356571495,0.58004691024745,-0.00924610139194368,-0.0539256011742644,0.0354333983903771,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014792_pub2_data","5::overall",5,"overall","Complications related to nutritional support",12,-0.0747793173750249,-0.828551252960435,0.678992618210385,0.00433941067359837,-0.0234798482558538,0.0321586696030505,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD014792_pub2_data","6::overall",6,"overall","Postoperative pancreatic fistula",7,-0.406572947982363,-0.952266036871319,0.139120140906593,-0.0468325023467029,-0.0889917070990474,-0.00467329759435842,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014802_pub2_data","9::overall",9,"overall","Adverse events: hypoglycaemia (88 hours after drug bolus, or up to 4 years + 11 months)",2,1.6644118929259,0.403250758588127,2.92557302726368,0.112931288379138,-0.0445400377562572,0.270402614514533,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014820_pub2_data","1::overall",1,"overall","Acute kidney injury",138,-0.055664782605207,-0.114552805545963,0.00322324033554924,0.00303281159813803,-0.000380896341076512,0.00644651953735257,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014820_pub2_data","2::overall",2,"overall","Death (any cause)",128,-0.105772294109357,-0.172168629129011,-0.0393759590897038,-0.00284567477092518,-0.00951869909870166,0.0038273495568513,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014820_pub2_data","3::overall",3,"overall","Dialysis",96,0.157406194571975,0.0276526858619294,0.287159703282021,0.000656382341477141,-0.00498515100859471,0.006297915691549,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014820_pub2_data","5::overall",5,"overall","Change in serum cystatin C [mg/L]",44,0.112381916664484,-0.173431489312451,0.39819532264142,-0.00210176991623519,-0.014937496749091,0.0107339569166206,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014820_pub2_data","8::overall",8,"overall","Adverse events: stroke",45,-0.155566447476155,-0.426754195719513,0.115621300767202,-0.00925804731197379,-0.0148144386948878,-0.00370165592905979,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014833_pub2_data","8::overall",8,"overall","Breastfeeding exclusivity short-term 1 to 3 months post-intervention",5,0.439593099344258,0.000473243372982213,0.878712955315534,0.100578354047898,-0.00478043961276382,0.205937147708561,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014844_pub2_data","1::overall",1,"overall","Uterine infection",6,-0.271180192017009,-0.804470992491434,0.262110608457416,-0.0120362318474431,-0.0213359376682806,-0.0027365260266056,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014844_pub2_data","10::1",10,"1","Subgroup: uterine infection by antibiotic class",5,-0.230053754595704,-0.772126411112303,0.312018901920894,-0.0112813941613306,-0.0204256085364891,-0.00213717978617207,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD014844_pub2_data","12::1",12,"1","Subgroup: uterine infection by administration route",4,-0.316906637291152,-0.979395117731808,0.345581843149504,-0.0116931756074732,-0.0207932027190925,-0.00259314849585394,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD014844_pub2_data","7::overall",7,"overall","Hospitalisation for treatment of infection",3,-0.263701360795181,-0.907069345572377,0.379666623982015,3.25314250279344e-05,-0.010523478038402,0.0105885408884579,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014844_pub2_data","8::overall",8,"overall","Sensitivity analysis: uterine infection – studies at low risk of bias",3,-0.588493078835859,-1.01972017477743,-0.157265982894283,-0.0221210563108462,-0.051038147353135,0.00679603473144252,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014852_pub2_data","21::overall",21,"overall","Complication (hyper/hypoglycaemia) during intervention phase",3,0.107872601331298,-2.63504301389956,2.85078821656215,-0.0688724062455452,-0.208907863405547,0.0711630509144568,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD014855_pub2_data","2::1",2,"1","Wound infection",8,0.723976647236185,0.0592695753909671,1.3886837190814,0.0761367920563292,-0.0198400004414648,0.172113584554123,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014855_pub2_data","4::1",4,"1","Mortality",8,0.956461410751273,-0.18897333453003,2.10189615603258,0.0462651994165581,0.00303872351703832,0.0894916753160778,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014869_pub2_data","1::overall",1,"overall"," All-cause mortality (between  1 and 5 years)",8,0.00729772924796753,-0.296981769659763,0.311577228155698,-0.0154469898497303,-0.0399751936769019,0.00908121397744135,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD014891_pub2_data","2::overall",2,"overall","Corrected distance visual acuity worse than 6/6 ",2,0.0569307321056924,-0.546468586425056,0.660330050636441,-6.89255591246728e-05,-0.0930987050550218,0.0929608539367724,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD014914_pub2_data","8::overall",8,"overall","Sneezing (continuous) (prevention)",2,-1.94085556557813,-3.73913358633815,-0.142577544818111,-0.11878928426054,-0.294490043656691,0.0569114751356098,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014920_pub2_data","1::overall",1,"overall","Acute myocardial infarction (short term < 30 days)",2,-1.2643263028558,-3.879156607378,1.35050400166641,-0.0403565512456768,-0.0653542661086364,-0.0153588363827172,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD014935_pub2_data","1::overall",1,"overall","All-cause mortality",3,0.0275873316526231,-1.10345256881836,1.15862723212361,-0.00547498439854397,-0.114207583823385,0.103257615026297,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD014937_pub2_data","14::overall",14,"overall","Subgroup analysis: acute kidney injury by definition",14,-0.528658483913378,-1.04250407583191,-0.0148128919948455,-0.0682003151672229,-0.139949487612651,0.00354885727820543,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014937_pub2_data","17::overall",17,"overall","Sensitivity analysis: any use of KRT (only studies with ""some concerns""  or a ""low"" overall risk of bias)",23,-0.359757201186382,-0.806374283536275,0.0868598811635107,-0.0108513044423716,-0.0212636581599446,-0.000438950724798583,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014937_pub2_data","18::overall",18,"overall","Sensitivity analysis: any use of KRT (placebo-controlled studies)",15,-0.808714813372781,-1.36373707980369,-0.253692546941873,-0.0246835809313562,-0.0506549699752209,0.00128780811250861,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014937_pub2_data","2::overall",2,"overall","Any use of kidney replacement therapy",46,0.00164432376149952,-0.177646783974059,0.180935431497058,-0.0115180189059566,-0.0195256062096775,-0.0035104316022356,FALSE,TRUE,FALSE,"direction_and_significance",TRUE,TRUE
"CD014937_pub2_data","21::overall",21,"overall","Subgroup analysis: any use of KRT by type of diuretic",44,-0.275724014286095,-0.600093466414589,0.0486454378423989,-0.00978375043840675,-0.0169108462637193,-0.0026566546130942,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014937_pub2_data","6::overall",6,"overall","Changes in serum creatinine within 30 days (mg/dL]",15,-0.179099250314711,-0.489942942559652,0.131744441930231,-0.0452616844953493,-0.0864990569801373,-0.00402431201056133,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014941_pub2_data","18::overall",18,"overall","Cenobamate versus placebo - subgroup analysis, any serious adverse event",4,0.0798239786403203,-0.53096371117519,0.690611668455831,-0.00378765022144231,-0.0313829384181385,0.0238076379752538,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD014941_pub2_data","6::overall",6,"overall","Withdrawal from the study due to adverse events",2,1.03002917820382,0.235366047398476,1.82469230900917,0.0571503741258227,-0.0240418965070339,0.138342644758679,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014959_pub2_data","14::overall",14,"overall","Proportion of people with non-serious adverse events",3,2.35116496919316,0.904005138198953,3.79832480018736,0.0322766818592607,-0.0049266851778673,0.0694800488963888,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014959_pub2_data","16::overall",16,"overall","Sensitivity analysis: non-serious adverse events (worst-case scenario)",3,3.56933130459306,1.5293586964615,5.60930391272461,0.123609145403552,-0.00949260665715396,0.256710897464258,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014959_pub2_data","4::overall",4,"overall","Sensitivity analysis: laboratory-confirmed leptospirosis (worst-case scenario)",6,-0.362380246815706,-1.53652493725206,0.811764443620648,0.0339565056103669,-0.0730331325114738,0.140946143732208,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD014959_pub2_data","9::overall",9,"overall","Sensitivity analysis: clinical diagnosis of leptospirosis regardless of the presence of laboratory confirmation (best-case scenario)",4,-1.22840621836499,-2.05723080167738,-0.399581635052589,-0.114614275718392,-0.235426814228273,0.00619826279148963,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014964_pub2_data","3::2",3,"2","Number of attempts (Types of ultrasound guidance: preprocedural versus real‐time)",22,-0.196926148703528,-0.779377309245159,0.385525011838103,-0.0151445384003295,-0.0248457617593877,-0.0054433150412713,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014964_pub2_data","5::overall",5,"overall","Technical failure of neuraxial anaesthesia",43,-0.115340351590656,-0.497187971495875,0.266507268314562,-0.0111266018902213,-0.0191331069941591,-0.0031200967862835,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014964_pub2_data","7::overall",7,"overall","Any adverse events",15,-0.441812771189237,-0.809343136072485,-0.0742824063059888,-0.0334316819663527,-0.0751824725662858,0.00831910863358042,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD014965_pub2_data","13::2",13,"2","Other side effects: somnolence",3,1.79556652354355,0.921499791922286,2.66963325516482,0.193067716191765,-0.0200193556350139,0.406154788018544,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD014965_pub2_data","18::1",18,"1","Other side effects: hypersalivation",4,1.30602145263919,-0.0440796108878407,2.65612251616622,0.0799355983826039,0.0282692527916537,0.131601943973554,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014965_pub2_data","19::1",19,"1","Other side effects: tremor",4,1.56619127393998,-0.036216713487411,3.16859926136738,0.0632557452882086,0.00289818468885378,0.123613305887563,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014965_pub2_data","2::1",2,"1","Aggression",8,0.908186857706642,0.176115247046524,1.64025846836676,0.0564140238283917,-0.00746131218837229,0.120289359845156,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014965_pub2_data","3::1",3,"1","Weight gain above clinically relevant thresholds",3,1.25102413675878,-0.133525812114522,2.63557408563207,0.112246563381958,0.0211510945317571,0.203342032232158,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD014965_pub2_data","5::2",5,"2","Extrapyramidal side effects: any extrapyramidal symptom",3,0.928583623669102,-0.125389811127032,1.98255705846524,0.111584701221073,0.00953168012723582,0.213637722314909,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014965_pub2_data","7::overall",7,"overall","Other side effects: dyskinesia",2,0.0389095945711778,-1.91874216703049,1.99656135617284,-0.0169135872492165,-0.0712025361648681,0.0373753616664351,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD014966_pub2_data","1::overall",1,"overall","Kidney graft loss",79,-0.115244598093911,-0.204772184218796,-0.025717011969027,-0.00754857896946967,-0.0206962883130379,0.00559913037409851,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD014967_pub2_data","1::overall",1,"overall","Proportion of infants who achieve seizure control after the first loading dose of ASM",15,-0.0551977406992684,-0.764032485555474,0.653637004156938,0.0128761787620911,-0.152685521533276,0.178437879057458,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD014967_pub2_data","4::overall",4,"overall","Requirement for mechanical ventilation",13,0.584954963813156,-3.8305411766637e-05,1.16994823303808,0.0727483858233435,0.00519997105226055,0.140296800594427,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD014967_pub2_data","6::overall",6,"overall","Bradycardia",9,-0.24781212624168,-0.607957362528103,0.112333110044743,0.00159385731486407,-0.0543934270921422,0.0575811417218704,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015003_pub2_data","2::overall",2,"overall","Non-fatal myocardial infarction",3,0.726750686350595,-0.459271097755708,1.9127724704569,0.0484794473693998,0.0213452130306558,0.0756136817081439,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","10::overall",10,"overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): sensitivity analysis by timing of effect",8,-0.439547778978076,-0.862356260083946,-0.0167392978722061,-0.0864724504657989,-0.18390803914628,0.0109631382146824,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","24::overall",24,"overall","Adherence to clinical guideline-recommended care (proportion of residents with adequate antipsychotic therapy)",2,1.97657465198053,-0.185164372024617,4.13831367598568,0.155828588552592,0.0382953749805255,0.273361802124659,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","25::overall",25,"overall","Adherence to clinical guideline-recommended care (proportion of residents with adequate antipsychotic therapy, two arms combined)",2,1.313035113194,-0.873930466180089,3.50000069256809,0.155828588552592,0.0382953749805255,0.273361802124659,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","35::overall",35,"overall","Any hospital admission (proportion of residents with at least one hospital admission)",13,-0.280637871204549,-0.554949261752266,-0.00632648065683261,-0.0445871948021004,-0.0969539658705948,0.00777957626639402,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","36::overall",36,"overall","Any hospital admission (proportion of residents with at least one hospital admission): sensitivity analysis by risk of bias",13,-0.280637871204549,-0.554949261752266,-0.00632648065683267,-0.0445871948021004,-0.0969539658705948,0.00777957626639399,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","37::overall",37,"overall","Any hospital admission (proportion of residents with at least one hospital admission): sensitivity by timing of effect",13,-0.280637871204549,-0.554949261752266,-0.00632648065683261,-0.0445871948021004,-0.0969539658705948,0.00777957626639401,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","5::overall",5,"overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission)",8,-0.439547778978076,-0.862356260083945,-0.016739297872206,-0.086472450465799,-0.18390803914628,0.0109631382146824,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","6::overall",6,"overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): subgroup analysis by EPOC category",8,-0.439547778978076,-0.862356260083945,-0.016739297872206,-0.086472450465799,-0.18390803914628,0.0109631382146824,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","7::overall",7,"overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): subgroup analysis by type of care provided",8,-0.439547778978076,-0.862356260083945,-0.0167392978722061,-0.086472450465799,-0.18390803914628,0.0109631382146824,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","8::overall",8,"overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): subgroup analysis by resident's condition",8,-0.439547778978076,-0.862356260083945,-0.0167392978722061,-0.0864724504657989,-0.18390803914628,0.0109631382146824,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015014_pub2_data","9::overall",9,"overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): sensitivity analysis by risk of bias",8,-0.439547778978076,-0.862356260083946,-0.0167392978722061,-0.0864724504657989,-0.18390803914628,0.0109631382146824,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015033_pub2_data","13::overall",13,"overall","Non-serious averse events. Worst-best case scenario sensitivity analysis",3,0.022012943456982,-0.443080562652368,0.487106449566332,-0.0214348258234762,-0.0899913149639113,0.0471216633169589,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD015033_pub2_data","21::overall",21,"overall","Imaging response. Proportion of participants without a normal ultrasound (range from 5 months to 12 months)",4,-0.680001069715577,-1.58292553958036,0.222923400149208,-0.113109355099222,-0.222488119216347,-0.00373059098209801,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015033_pub2_data","3::overall",3,"overall","All-cause mortality. Worst-best case scenario sensitivity analysis",13,0.994697795647324,-0.00690805363739055,1.99630364493204,0.112758668342098,0.0612778207770327,0.164239515907163,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015038_pub2_data","15::overall",15,"overall","Negative appendectomy rate (normal histology)",5,1.34792045462569,0.649555666487771,2.0462852427636,0.0215037217865526,-0.0889050610947435,0.131912504667849,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015046_pub2_data","1::overall",1,"overall","Adverse events&nbsp;",3,-0.296739517198805,-1.18069929214569,0.587220257748077,0.0084456800101387,-0.219397905778985,0.236289265799263,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015084_pub2_data","6::overall",6,"overall","Withdrawals due to adverse events",6,0.557284801462005,-0.0264527269690603,1.14102232989307,0.112478802484153,0.0250845366624583,0.199873068305849,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015087_pub2_data","1::overall",1,"overall","Adverse events",13,-0.561625473117096,-1.18225731803673,0.0590063718025354,-0.0857054923835867,-0.159748217912471,-0.0116627668547029,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015087_pub2_data","15::overall",15,"overall","Nausea and/or vomiting",5,-1.12798916991363,-2.34800469289483,0.0920263530675787,-0.223266964784644,-0.395802139661914,-0.0507317899073742,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015123_pub2_data","1::overall",1,"overall","Number of participants with at least one SAE",3,-0.628222290372192,-0.947589902862516,-0.308854677881867,-0.0701757363649636,-0.167504212998925,0.0271527402689978,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015134_pub2_data","3::overall",3,"overall","Stillbirth",5,-0.127836740104723,-0.718300038892747,0.462626558683301,0.000114466798997551,-0.00188856452866104,0.00211749812665614,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015140_pub2_data","14::overall",14,"overall","Risk of brain relapse",3,-0.309483974291088,-2.33066935120605,1.71170140262387,0.0143296029172146,-0.166258575497593,0.194917781332022,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD015160_pub2_data","2::overall",2,"overall","Mortality (defined as all‐cause mortality) within 30 days of repair",11,0.386525190813118,-0.208091660011653,0.981142041637889,0.050721230182964,0.014405529176493,0.0870369311894351,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015160_pub2_data","3::overall",3,"overall","Surgical site infections (as defined by the included studies) within 90 days of repair",6,0.534405778482268,-0.736657043752147,1.80546860071668,0.0587574497410464,0.0137657824198324,0.103749117062261,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015192_pub2_data","2::overall",2,"overall","All-cause mortality",8,-0.143948027486377,-0.692966836333348,0.405070781360595,0.00148062538552923,-0.0133984633430467,0.0163597141141052,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015213_pub2_data","10::overall",10,"overall","Length of hospital stay",19,-0.0621674853528861,-0.902667327100338,0.778332356394566,0.00850694372934254,-0.010503757614406,0.0275176450730911,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015213_pub2_data","3::overall",3,"overall","Recurrence rate",27,-0.447341708263052,-0.894731594199405,4.8177673300287e-05,-0.0302726473809539,-0.0512561027315447,-0.00928919203036302,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015215_pub2_data","11::overall",11,"overall","Presence/persistence of OME, randomised by child, measured by otoscopy (medium-term)",4,-1.62099848960564,-2.2503087957385,-0.991688183472767,-0.201770290522924,-0.410656165506647,0.00711558446079888,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015215_pub2_data","12::overall",12,"overall","Presence/persistence of OME, randomised by child, measured by tympanometry (medium-term)",5,-1.34120351476976,-1.8224572813539,-0.85994974818562,-0.211936831697379,-0.435716112325036,0.011842448930278,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015215_pub2_data","18::overall",18,"overall","Adverse event: segmental atrophy (long-term)",4,1.27140953009332,0.765698135858096,1.77712092432855,0.0926014899025425,-0.0211521886687198,0.206355168473805,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015215_pub2_data","5::overall",5,"overall","Persistence of OME: randomised by child (very short-term)",8,-0.275249497738547,-1.28964176659318,0.739142771116081,0.00820761541538713,-0.0158800198244691,0.0322952506552433,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015215_pub2_data","6::overall",6,"overall","Persistence of OME: randomised by child (medium-term)",8,0.166903560038502,-1.19071162268977,1.52451874276677,-0.0601010619414235,-0.292159336076819,0.171957212193972,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015215_pub2_data","9::overall",9,"overall","Mean improvement in expressive language, randomised by child (medium-term)",5,0.00416388189351341,-0.737316133030543,0.74564389681757,-0.00225645347991477,-0.042157383307989,0.0376444763481595,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015219_pub2_data","13::overall",13,"overall","Need for admission to hospital (if ambulatory) – fixed-effect model",4,0.00200743873727421,-0.987367295764429,0.991382173238977,-0.00497392772109116,-0.0679988815271602,0.0580510260849779,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015219_pub2_data","6::overall",6,"overall","Need for critical or intensive care (any reason)",6,0.00116625733592993,-0.417118280286226,0.419450794958086,-0.000270526529861082,-0.0258164383563576,0.0252753852966355,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015254_pub2_data","6::overall",6,"overall","Persistence of OME (short-term)",10,-0.461221242177189,-0.969726791214264,0.0472843068598863,-0.0930300291539418,-0.183234303108717,-0.00282575519916652,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015254_pub2_data","8::overall",8,"overall","Sensitivity analysis: persistence (short-term) assuming ICC of 1.0 (complete correlation between ears) (Puhakka 1985)",10,-0.49834870003128,-1.01432478548751,0.0176273854249531,-0.109851858911439,-0.198175736413172,-0.0215279814097053,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015254_pub2_data","9::overall",9,"overall","Sensitivity analysis: persistence (short-term) assuming ICC of zero (no correlation between ears) (Puhakka 1985)",10,-0.498222061911873,-1.03370223818936,0.0372581143656159,-0.10689374409129,-0.197822197796948,-0.0159652903856321,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015255_pub2_data","16::overall",16,"overall","Persistence of OME (medium-term - up to 1 year)",2,-1.84172334821216,-3.17905652152315,-0.504390174901173,-0.324974092696033,-0.729871764200983,0.0799235788089175,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD015255_pub2_data","17::overall",17,"overall","Acute otitis media (very short-term - up to 6 weeks)",3,0.0995637699395986,-1.28768558993489,1.48681312981409,-0.00352977787709749,-0.109438304772225,0.10237874901803,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015255_pub2_data","7::overall",7,"overall","Disease-specific quality of life (very short-term - up to 6 weeks)",4,-0.768272749108542,-1.50997761001869,-0.0265678881983941,-0.149056085442196,-0.307173320004404,0.00906114912001224,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015255_pub2_data","9::overall",9,"overall","Persistence of OME (very short-term - up to 6 weeks)",8,-0.69565164792141,-1.41759451186505,0.0262912160222271,-0.173307898390782,-0.322402614468152,-0.0242131823134116,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015314_pub2_data","1::4",1,"4","Tobacco cessation at longest follow-up",3,0.453539222157308,-0.10638593339899,1.01346437771361,0.0560768268064003,0.0152187847954699,0.0969348688173306,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015331_pub2_data","38::overall",38,"overall","Global state - number of participants with clinically important change in global state",2,0.620830987103026,-0.00196179835171617,1.24362377255777,0.127138700300352,0.00148673290646173,0.252790667694242,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015331_pub2_data","45::overall",45,"overall","Service use - admission to hospital (separated time points)",15,-0.0680474469707206,-0.361220680309832,0.225125786368391,0.00166844359634768,-0.0296712001348248,0.0330080873275202,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015331_pub2_data","49::overall",49,"overall","Leaving the study early - for any reason - overall acceptability (separated time points)",51,-0.257802718830493,-0.442123409006143,-0.0734820286548435,-0.0264378037879006,-0.05335533542476,0.000479727848958826,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015331_pub2_data","66::overall",66,"overall","Behaviour - occurence of violent incidents",2,-0.0338514559628889,-2.0048231251027,1.93712021317692,0.0228327130468416,-0.0456092771012629,0.091274703194946,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015331_pub2_data","9::overall",9,"overall","Mental state - specific: number of participants with clinically important change in positive symptoms (combined time points)",2,0.815051831721705,-0.0094448852832324,1.63954854872664,0.192494334046052,0.00355733082440862,0.381431337267695,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015332_pub2_data","16::overall",16,"overall","Mortality – mortality due to natural causes ",12,-0.531405378455448,-1.61470748454191,0.55189672763101,-0.0727856569440728,-0.131684370041103,-0.0138869438470425,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015332_pub2_data","22::overall",22,"overall","Adverse events – participants with at least 1 adverse event",6,-0.64611962403296,-1.27673852128407,-0.0155007267818491,-0.0413690686687715,-0.103593554573782,0.0208554172362386,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015332_pub2_data","32::overall",32,"overall","Behaviour – violent incidents (separated time points)",2,0.140151939402547,-1.84160120637201,2.1219050851771,-0.0177758573731697,-0.101071095348328,0.0655193806019891,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015373_pub2_data","11::3",11,"3","Adverse events (total): duration of administration subgroup analysis",3,2.20297778156645,-0.136075618785215,4.54203118191812,0.305829032058789,0.00464509068979058,0.607012973427788,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015373_pub2_data","23::overall",23,"overall","Tolerability",8,0.507094797797082,-0.505004434958881,1.51919403055305,0.0444705582103977,0.00757194717615613,0.0813691692446392,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015387_pub2_data","7::overall",7,"overall","Thirty-day case fatality",7,-0.577484010145841,-0.913741331272228,-0.241226689019454,-0.0372488904300244,-0.0977824857701063,0.0232847049100575,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015387_pub2_data","8::2",8,"2","Thirty-day case fatality: stratified by surgical approach",5,-0.552291350568688,-1.01682465547126,-0.0877580456661182,-0.0500685888589231,-0.140009420959049,0.0398722432412028,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015395_pub3_data","1::overall",1,"overall","All-cause mortality at day 28",2,-1.54030872055674,-4.14206476745135,1.06144732633787,-0.0109216825837332,-0.0169376121276952,-0.00490575303977115,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015432_pub2_data","3::overall",3,"overall","Pain intensity – as reported by the child, from 24 hours up to 7 days postintervention",14,0.0257786799340201,-0.713559281472286,0.765116641340326,-0.00808088850259824,-0.114873143066739,0.0987113660615423,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015443_pub2_data","10::overall",10,"overall","Mortality",15,-0.17706483378693,-0.765980002895707,0.411850335321847,0.00137257406494037,-0.00125323599232761,0.00399838412220836,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015476_pub2_data","12::overall",12,"overall","Serrated adenoma detection rate excluding studies that included patients with Lynch syndrome",6,0.543919650202995,0.314613602298574,0.773225698107416,0.014622700753988,-0.00310137111034352,0.0323467726183195,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015476_pub2_data","2::overall",2,"overall","Sessile serrated lesion detection rate",7,0.505784018742404,0.284427705551701,0.727140331933108,0.0133251803054642,-0.00302150830385679,0.0296718689147853,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015514_pub2_data","7::overall",7,"overall","Adverse events - outer retinal folds",3,-0.455532384308224,-1.22819525980858,0.317130491192132,-0.0684735917779343,-0.132063868006833,-0.00488331554903591,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015514_pub2_data","8::overall",8,"overall","Adverse events - binocular diplopia and elevated intraocular pressure at 6 months",2,-0.36446308187539,-2.70467528592126,1.97574912217048,0.0289248878270497,-0.157791932624099,0.215641708278198,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD015524_pub2_data","14::overall",14,"overall","Analysis 1.14. Outcome 6: Proportion of participants without improvement of steatosis: sensitivity analysis fixed-effect model",8,0.137845996894391,-0.584993903982129,0.86068589777091,-0.0160072821975777,-0.154967808032698,0.122953243637543,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015530_pub2_data","1::overall",1,"overall","Incidence of herpes zoster (up to 21 months after final dose)",5,-0.579895851608645,-1.19013980125461,0.0303480980373239,-0.0224890992813187,-0.0435254584093989,-0.00145274015323854,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015530_pub2_data","3::overall",3,"overall","Adverse events of any grade (up to 30 days after final dose)",3,0.331442106930818,0.01378434376627,0.649099870095365,0.0403873211988607,-0.0187828347490553,0.0995574771467766,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD015532_data","10::overall",10,"overall","Need for renal replacement therapy",6,-0.448142302876319,-0.717488193058527,-0.178796412694111,-0.124776338155894,-0.251009792403133,0.00145711609134513,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015532_data","14::overall",14,"overall","ICU length of stay",3,1.94267577203542,0.0238774772038859,3.86147406686696,0.0752290303390839,-0.0373625042807949,0.187820564958963,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015532_data","15::overall",15,"overall","Hospital length of stay",4,0.0771265700461175,-2.04741469133875,2.20166783143099,-0.0751023800764311,-0.291703581244571,0.141498821091709,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015532_data","9::overall",9,"overall","Ventilatory problems",5,-0.394085862349389,-0.649101754118,-0.139069970580778,-0.064135594559835,-0.1363167454489,0.00804555632923032,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD015536_pub2_data","4::2",4,"2","Proportion of people with serious adverse events (co-interventions)",5,-1.02871166838152,-2.05313850636379,-0.00428483039925998,0.00326950335187534,-0.126123813591953,0.132662820295704,TRUE,FALSE,FALSE,"direction_and_significance",TRUE,TRUE
"CD015536_pub2_data","5::overall",5,"overall","Proportion of people without histological improvement",4,-1.38020094462444,-2.95352025199125,0.193118362742368,-0.401465581227486,-0.678155397637061,-0.124775764817911,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015551_pub2_data","1::overall",1,"overall","Incidence of herpes zoster (up to 29.4 months after final dose)",5,-0.958014004721253,-1.9175138839287,0.00148587448618887,-0.0237351081096693,-0.0455862110110263,-0.00188400520831231,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015573_data","2::overall",2,"overall","Minor complications of treatment",5,-0.5693509657429,-1.4519183443947,0.313216412908896,-0.0552033890675948,-0.100200787738566,-0.0102059903966234,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015584_pub2_data","4::overall",4,"overall","Providers' ease of placement",16,0.319588429784621,-0.24382402237537,0.883000881944612,0.0476797887379232,0.0127439146981065,0.08261566277774,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015584_pub2_data","6::1",6,"1","Placement success",12,0.453093406916401,0.0204708767802761,0.885715937052526,0.022155885624131,-0.0183890462595747,0.0627008175078367,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD015588_pub2_data","20::overall",20,"overall","3P-MACE",10,-0.132901728782706,-0.22600238988411,-0.0398010676813017,-0.00758106227297121,-0.0176607290306299,0.00249860448468751,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015588_pub2_data","31::overall",31,"overall","Doubling of serum creatinine",2,-0.369066299371323,-0.633047981496295,-0.105084617246351,-0.0189675863612764,-0.0426610848311286,0.00472591210857584,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD015588_pub2_data","4::overall",4,"overall","Cardiovascular death (Hazard Ratio)",17,-0.0824468954815819,-0.733328838815233,0.568435047852069,0.000188417176645229,-0.0153365619222897,0.0157133962755802,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015588_pub2_data","42::overall",42,"overall","Hypoglycaemia",18,-0.0858587326807483,-0.151848726222213,-0.0198687391392833,-0.00493401234836502,-0.0126464293269827,0.00277840463025265,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015588_pub2_data","44::overall",44,"overall","Hypoglycaemia requiring third-party assistance",17,-0.295644408632598,-0.455030361811392,-0.136258455453805,-0.00441414889374466,-0.0110552154205175,0.00222691763302814,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015673_pub2_data","5::overall",5,"overall","Number of drinks per drinking day",10,-0.0437516842037922,-0.556538387788115,0.469035019380531,0.0077241714933864,-0.117497621102429,0.132945964089202,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015673_pub2_data","7::overall",7,"overall","Serious adverse events",4,-1.35134865594596,-2.84709488591507,0.144397574023161,-0.0289242688327286,-0.0552665222145691,-0.00258201545088812,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015698_pub2_data","6::overall",6,"overall","Intra-abdominal abscess",2,0.0609131206205213,-1.88300212829701,2.00482836953805,-0.00716259851715369,-0.0549834471474413,0.0406582501131339,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015711_pub2_data","2::overall",2,"overall","Spectacle independence for intermediate vision",2,-1.54348629374014,-3.91475974148004,0.827787153999759,-0.123866666666667,-0.24122005467418,-0.00651327865915372,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015711_pub2_data","4::overall",4,"overall","Frequency of any ocular AE",2,0.15938546957436,-2.33690792751679,2.6556788666655,-0.0253789473684211,-0.397661947820909,0.346904053084067,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD015721_pub2_data","2::overall",2,"overall","Excellent functional outcome: mRS score < 2 within 90 days",6,0.00984393631437958,-0.180105993285054,0.199793865913814,-0.00549530266631943,-0.0379132647110678,0.026922659378429,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD015721_pub2_data","4::overall",4,"overall","Asymptomatic intracranial haemorrhage within 90 days",6,0.18067240914421,-0.00223905142333308,0.363583869711753,0.0373177268083985,0.0016206536617919,0.0730147999550052,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015746_pub2_data","1::1",1,"1","Acute typhoid fever",7,-0.913207153581095,-2.18193176272347,0.355517455561277,-0.00657582437846004,-0.0128255248478482,-0.000326123909071866,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015746_pub2_data","2::1",2,"1","All-cause mortality",8,-0.770597485997211,-1.56216900277386,0.0209740307794379,-0.00041630732757506,-0.000621094479722936,-0.000211520175427184,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015746_pub2_data","3::2",3,"2","Adverse events",4,-0.0562653624868705,-0.438802682570405,0.326271957596664,0.000155419891157452,-0.00184204784633275,0.00215288762864765,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015746_pub2_data","4::2",4,"2","Serious adverse events",2,0.696814462549679,-1.45230360493601,2.84593253003537,0.00266666666666667,5.68680603862315e-05,0.0052764652729471,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015746_pub2_data","4::3",4,"3","Serious adverse events",5,-0.243852797366716,-0.427570200111384,-0.0601353946220472,-0.00110971635297258,-0.00386729605610349,0.00164786335015833,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015779_data","5::overall",5,"overall","All-cause mortality (latent RHD)",3,-2.55243161509125,-3.21076888610593,-1.89409434407657,-0.189980523997369,-0.423831995206713,0.0438709472119762,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015824_pub2_data","2::2",2,"2","Mortality",4,-0.164782125823178,-1.07722628756061,0.747662035914253,0.00518303000828143,-0.0176320449603993,0.0279981049769621,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015824_pub2_data","3::1",3,"1","Hospitalisation",2,-1.41028845259548,-2.18926081886549,-0.63131608632548,-0.0627899293513194,-0.13287547719795,0.00729561849531137,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD015824_pub2_data","6::2",6,"2","Worsening in World Health Organization functional class ",5,0.0900763675342516,-0.47613553887492,0.656288273943424,-0.00940653540355075,-0.0368468767716105,0.018033805964509,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015824_pub2_data","9::1",9,"1","Withdrawal from the trial",3,-0.310809096623767,-0.612721244800202,-0.00889694844733152,-0.0441846558535474,-0.108429031298911,0.0200597195918166,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD015849_pub2_data","1::overall",1,"overall","All-cause death",41,-0.172262845924745,-0.287859706818699,-0.056665985030792,-0.000476660290895169,-0.00671701488465776,0.00576369430286742,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015849_pub2_data","12::overall",12,"overall","Composite kidney outcome (Hazard ratio)",9,0.719612982655567,0.0723470198854709,1.36687894542566,0.0412770437155713,-0.0130204095638513,0.0955744969949939,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015849_pub2_data","14::overall",14,"overall","Severe hypoglycaemia (Hazard ratio)",8,0.781339893860187,0.128152512674325,1.43452727504605,0.0591367594965234,-0.00167705463553482,0.119950573628582,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015849_pub2_data","18::overall",18,"overall","Myocardial infarction (undefined)",3,-0.301228858230932,-0.601319633243049,-0.00113808321881365,-0.00714010261436958,-0.0379808901360491,0.02370068490731,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015849_pub2_data","21::overall",21,"overall","Nonfatal stroke",2,-0.438310890658298,-1.19291324036053,0.316291459043933,-0.0242787863110203,-0.0408005961606757,-0.00775697646136494,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015849_pub2_data","27::overall",27,"overall","Heart failure",2,1.1883611858538,-0.990726500084882,3.36744887179247,0.0076494271155772,0.000175361580958749,0.0151234926501957,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD015849_pub2_data","3::overall",3,"overall","Cardiovascular death",28,-0.151799707490308,-0.380500654692085,0.0769012397114691,0.000584909318792432,-0.00443876360617602,0.00560858224376088,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015849_pub2_data","41::overall",41,"overall","Hypoglycaemia",3,0.083974637678506,-0.96300497636096,1.13095425171797,-0.00234935526565699,-0.0659903848740268,0.0612916743427128,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015849_pub2_data","8::overall",8,"overall","4-point MACE (Hazard ratio)",8,-0.0795940690596724,-0.905039386041935,0.74585124792259,0.00181242281378068,-0.00264340793848525,0.0062682535660466,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015854_data","3::1",3,"1","Improvement in muscle strength (assessed with change in MMT8) (GIV analysis)",4,1.21698976025534,-0.136228411363478,2.57020793187415,0.324796328446429,0.0174577374901055,0.632134919402753,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015854_data","5::1",5,"1","Serious adverse event",3,0.0802872515985147,-1.89214971610831,2.05272421930534,-0.0474240060021518,-0.313855588492137,0.219007576487834,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015854_data","6::3",6,"3","Serious adverse event",3,-0.897830719247982,-2.78906222724623,0.993400788750269,-0.272815533980582,-0.529818869145548,-0.0158121988156172,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD015855_data","4::2",4,"2","Improvement of muscle strength (assessed with change in MMT or other validated muscle score)",4,0.565273591950018,0.0547913064295652,1.07575587747047,0.120240980030846,-0.00471912007429458,0.245201080135986,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD015855_data","8::overall",8,"overall","Withdrawals for either lack of benefit or adverse events",3,-0.0440319935897666,-1.53111166885501,1.44304768167547,0.0136358205262115,-0.050433013904465,0.077704654956888,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD015875_data","10::overall",10,"overall","Hip circumference (cm) (10 to 19 years)",2,-0.209872273568972,-1.13270295225696,0.712958405119019,0.00279805291213443,-0.0879210434048784,0.0935171492291473,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD015932_pub2_data","1::2",1,"2","All-cause mortality",3,-1.07042404221875,-2.79705032254691,0.656202238109417,-0.0755527225725028,-0.116722749961596,-0.0343826951834098,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD015932_pub2_data","12::5",12,"5","Rate of pulmonary complications – pneumonia",3,-0.950788080156242,-1.85144374911132,-0.0501324112011653,-0.174061107400731,-0.38083237739845,0.0327101625969879,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD015932_pub2_data","2::2",2,"2","ICU length of stay",3,-0.558154675344505,-1.59564079307077,0.479331442381761,-0.0649162761056351,-0.125590923985934,-0.00424162822533628,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD016002_data","1::1",1,"1","Death",18,-0.428001475166847,-1.33518231189461,0.479179361560914,-0.0633254317643075,-0.125796221313739,-0.000854642214876071,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD016031_data","11::overall",11,"overall","Comparison 1: Anterior vs posterior, Outcome 11: Mortality, late (≥ 24 months, categorical data)",3,0.123841430176046,-0.827920242040741,1.07560310239283,-0.00335272259729572,-0.0476089912259368,0.0409035460313454,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016031_data","13::5",13,"5","Comparison 2: Anterior vs lateral, Outcome 13: Adverse events, implant related (categorical data)",2,0.318046574520617,-0.796457798281548,1.43255094732278,-0.00324479242852826,-0.0746834134624344,0.0681938286053778,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016031_data","13::overall",13,"overall","Comparison 1: Anterior vs posterior, Outcome 13: Pain, intermediate (4-24 months, categorical data)",5,0.107611862064577,-0.629532215760906,0.84475593989006,-0.012237395228161,-0.0482462020313817,0.0237714115750596,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016031_data","15::1",15,"1","Comparison 2: Anterior vs lateral, Outcome 15: Operative details (Continuous data)",14,-0.993725269890321,-1.70940872524655,-0.278041814534089,-0.0189808415672849,-0.0393343962714562,0.00137271313688626,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD016031_data","15::2",15,"2","Comparison 2: Anterior vs lateral, Outcome 15: Operative details (Continuous data)",6,0.844091636761621,-0.233887464123563,1.92207073764681,0.0361177039322057,0.00253362155267377,0.0697017863117376,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD016031_data","15::3",15,"3","Comparison 2: Anterior vs lateral, Outcome 15: Operative details (Continuous data)",6,-0.105579553615369,-1.42525340666722,1.21409429943649,0.000454798978164568,-0.0356979429301304,0.0366075408864595,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD016058_pub2_data","3::overall",3,"overall","Vaping cessation at between 3 & 6 months",9,0.465586299960372,-0.0176274915030943,0.948800091423839,0.094356089345527,0.00806751869394638,0.180644659997108,FALSE,TRUE,TRUE,"significance_only",TRUE,FALSE
"CD016064_data","5::1",5,"1","Multifactorial interventions (grouped by alignment with QCA theory): Risk of falling sensitivity analyses: excluding trials at high risk of bias",13,-0.0731073313258786,-0.548513812990718,0.402299150338961,0.0162084790444035,-0.0220883219201325,0.0545052800089395,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD016119_data","20::overall",20,"overall","Complications (unspecified)",3,0.010434506210145,-1.53109895143539,1.55196796385568,-0.0050059205652473,-0.0536446313849097,0.0436327902544151,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016119_data","3::overall",3,"overall","Size of fibroid on incidence of haemorrhage",6,0.0733959709307592,-0.525096328637271,0.671888270498789,-0.0155752183787889,-0.0714660239728383,0.0403155872152604,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016120_data","3::overall",3,"overall","Haemorrhage",2,-0.134262521884646,-0.421308246549036,0.152783202779743,0.000238235286090741,-0.0282848330461418,0.0287613036183233,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016131_data","2::1",2,"1","Medically attended RSV-associated severe lower respiratory tract illness in infants",2,-1.81644118997276,-2.62991092928844,-1.00297145065709,-0.00986853424070365,-0.0215131196624575,0.00177605118105016,TRUE,FALSE,TRUE,"significance_only",TRUE,FALSE
"CD016131_data","3::overall",3,"overall","Mortality from illness caused by RSV",9,-0.0878733196940228,-1.17505394340899,0.999307304020942,0.044982155106917,0.00433465500984514,0.0856296552039889,FALSE,TRUE,FALSE,"direction_and_significance",TRUE,TRUE
"CD016131_data","5::1",5,"1","Serious adverse events (SAEs) related to vaccination",4,-0.1354563715032,-1.03748453937445,0.766571796368055,6.55792229365448e-06,-0.00047470343786294,0.000487819282450249,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016131_data","6::1",6,"1","Any unsolicited adverse events (spontaneously reported/ other adverse events)",4,0.0946709977754856,0.0488956796937072,0.140446315857264,0.00789581181229729,-0.00170670359428967,0.0174983272188842,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD016147_data","6::overall",6,"overall","Adverse effects (abdominal pain)",2,-0.119236584522769,-1.07578617150549,0.837313002459956,0.00144951205013027,-0.124507741126813,0.127406765227073,FALSE,FALSE,FALSE,"direction_only",FALSE,FALSE
"CD016148_data","2::overall",2,"overall","3rd or 4th degree tears",15,-0.413695006984715,-0.805726689271211,-0.0216633246982181,-0.00576643910086291,-0.0136644383574446,0.0021315601557188,TRUE,FALSE,TRUE,"significance_only",TRUE,TRUE
"CD016168_data","11::overall",11,"overall","Adverse effects – headache up to 24 hours",2,0.125281026811984,-0.7134619893997,0.964024043023668,-0.00160838780012609,-0.0316406271983462,0.028423851598094,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016168_data","2::overall",2,"overall","Severe maternal morbidity – ICU admission",4,0.391963200752807,-0.145935983087672,0.929862384593287,0.0178211688187387,0.00483216801294072,0.0308101696245366,FALSE,TRUE,TRUE,"significance_only",TRUE,TRUE
"CD016168_data","3::overall",3,"overall","Breastfeeding",3,-0.335016095371524,-0.782139298258091,0.112107107515043,-0.0270979603986156,-0.0510497779267336,-0.00314614287049764,FALSE,TRUE,TRUE,"significance_only",FALSE,FALSE
"CD016168_data","5::overall",5,"overall","Severe maternal morbidity – hysterectomy (non-randomised studies)",2,1.1234237508771,0.640487126522649,1.60636037523155,0.0729233472853018,-0.00300694171841535,0.148853636289019,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD016168_data","6::overall",6,"overall","Adverse effects – thromboembolic events",3,-0.194185066651227,-2.08306696411721,1.69469683081476,0.00221094291711175,-0.0246208328533635,0.029042718687587,FALSE,FALSE,FALSE,"direction_only",TRUE,TRUE
"CD016211_data","1::overall",1,"overall","Maternal sepsis",4,-0.43199609546437,-0.597180443098425,-0.266811747830315,-0.00406252903116841,-0.0096907068410749,0.00156564877873807,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD016211_data","2::2",2,"2","Maternal sepsis: subgroup analysis (polypharmacy vs monopharmacy)",4,-0.435092759704064,-0.601365776286879,-0.268819743121249,-0.00405764878410204,-0.00974038569362614,0.00162508812542207,TRUE,FALSE,TRUE,"significance_only",FALSE,FALSE
"CD016278_data","21::overall",21,"overall","Vomiting",2,-0.0361989363682753,-0.209087900435316,0.136690027698765,0.00573736572417546,-0.0165792861628678,0.0280540176112188,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
"CD016278_data","9::overall",9,"overall","Hysterectomy",2,-0.20467174973262,-1.66566496809171,1.25632146862647,0.000439599407720132,-0.00109090056760079,0.00197009938304106,FALSE,FALSE,FALSE,"direction_only",TRUE,FALSE
